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Musculoskeletal pain (MSK), such as low back pain (LBP), neck pain and 
widespread pain, is among the most common health problems in industrial countries. 
Subsequently, MSK is associated with substantial healthcare utilization and a leading 
cause of sick leave and work disability. The impact on individuals, families and 
working life is substantial and the societal costs are huge. Most patients have MSK 
with few or no objective findings. Psychosocial factors are of the most important 
predictors for long-term disability from MSK and subsequently different 
multidisciplinary treatment models (MDIs) have evolved over recent last decades. 
   
As part of this PhD project, a multidisciplinary intervention (MI) was developed, 
primarily aimed at a quicker return to work (RTW) for MSK patients. The MI 
involved a particular focus on work and psychosocial factors in addition to the 
somatic complaints and included strengthened patient education (PE) and 
communication in treatment. The MI was tested against the more established brief 
intervention (BI), which is mainly focused on musculoskeletal complaints. 
 
Aims 
The main purpose was to clarify whether MI can improve RTW rates within two 
years over BI in patients on sick leave due to MSK. Secondly, we aimed at 
identifying predictors for sustainable RTW (s-RTW) and compared patient health, 
functional ability and coping between groups during 12 months of follow-up. 
Methods 
A randomized controlled trial (RCT) was performed with MI and BI as equally sized 
intervention groups. Patients were referred to specialist healthcare by their general 
practitioners (GPs) and on sick leave for a maximum of 12 months with MSK. BI is 
based on the non-injury model (NIM), a non-directive communication and PE 
approach, and involves a physician and a physiotherapist in the treatment team. 
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Patients in the BI group met twice at the outpatient clinic: at baseline and at the two-
week follow-up stage. The MI was more comprehensive, involved the use of a novel 
educational communication tool, and focused particularly on psychosocial and work-
related factors. The MI was administered by a physician, a social worker and a 
physiotherapist on the treatment team, and the patients met three times in the 
outpatient clinic, at baseline, after two weeks and after three months. Data on work 
participation and sickness benefits were derived from the social insurance register, 
providing 100% response rate on follow-up data. Questionnaires to identify 
demographic and clinical variables were filled out by both groups at baseline, and at 
the three and 12-month follow-ups.  
 
Results 
Out of 534 patients referred by GPs, 284 patients (mean age=41.3 years, 53.9% 
women) were included and randomized to MI (n=141) and BI (n=143). The mean 
duration of sickness absence at baseline was 147 days. The treatment drop-out rate 
was low in both groups (MI: n=7, BI: n=15), indicating that both methods were 
feasible in a clinical setting. The results showed that MI hastened the RTW process 
through increased use of partial sick leave (PSL) in the first seven months of the 
study. At 12 months, there were no differences between groups in terms of either full 
RTW (f-RTW) (45%: both groups) or partial RTW (p-RTW) (MI=14%, BI=10%). 
The corresponding numbers at 24 months were: f-RTW: MI=43%, BI=37%, p-RTW: 
MI=13%, BI=6%. The MI predicted s-RTW, defined as increased work participation, 
compared to the baseline, for three consecutive months, at the three-month follow-up 
(OR=2.4), and the subgroup of patients who reported to have low support at work 
benefitted more from MI than BI. The belief that work was the cause of the pain 
predicted s-RTW at three months irrespective of the intervention. Anxiety/depression 
and duration of sick leave at baseline were risk factors for an s-RTW. 
 
Secondly, the MI hastened improvements in some of the clinical outcomes: anxiety, 
depression, somatization and physical functioning. Levels of pain and subjective 
health complaints (SHCs) followed the same course in the two groups. The MI group 
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used fewer healthcare services in terms of consulting a GP, at both the three and 12-
month follow-ups, as well as reported significantly better perceived coping, physical 
fitness and satisfaction with treatment than the BI group at 12 months.  
 
Conclusion 
An MI with a particular focus on work, psychosocial factors, PE and communication 
in therapy could speed up the RTW process and the process of improving from 
mental health complaints and physical functioning among workers on sick leave with 
MSK, compared to the effects of a BI. Patients receiving MI are more satisfied with 
treatment, report improved physical fitness and being able to cope with health 
complaints, and make lesser use of healthcare services, which could also confirm 
improved coping.  
Earlier reconnection with working life could be important, as the length of sick leave 
is a risk factor for RTW. The reported sense of improved coping in the MI group 
could be associated with a successful earlier reconnection with work or to faster 
improvements in clinical outcomes. It may also relate to the strengthened educational 
process and patient involvement in the MI, which can improve patient adherence to 
treatment and thereby improve a sense of coping.  
However, results so far do not advocate recommending MI before BI to patients on 
long-term sick leave with MSK, as effect sizes in this study are small to modest and 
BI performs equally well in the long run for most outcomes. Results should be further 
improved and cost-benefit analyses should be part of future studies. The identification 
of subgroups of patients who might benefit more from comprehensive treatment is 
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1. Introduction and theoretical framework 
1.1 Background 
According to the Global Study of Disease, musculoskeletal disorders (MSDs) are 
among the main contributors to years lived with disability globally (1, 2). MSDs 
include a wide range of inflammatory, degenerative and non-specific conditions 
affecting bones and joints with their adjacent structures, as well as muscles, tendons 
and ligaments. MSDs are highly prevalent in the general population and affect one in 
four adults across Europe (3). Subsequently, MSDs impose a significant direct cost 
burden on healthcare systems and on working life, as it is common within the 
workforce where it represents a major cause of sickness absence and long-term 
disability. MSK conditions constitute the major part of all MSDs, with LBP as the 
most frequent condition (2). Most cases of MSK are non-specific with few or no 
objective findings; together with mental health problems, MSK represents the most 
common reason for presentations to primary care where the majority of the cases are 
managed (3, 4). However, the real burden of overall costs for patients with MSK is 
connected to a relatively small number of cases with chronic MSK (5-7).  
The number of people on long-term work incapacity benefits due to MSK has, in 
spite of improvements in general health and mortality, increased substantially in 
Western countries in recent decades (8). In Norway, MSK accounts for about 40% of 
long-term sick leave cases, with LBP as the most frequent diagnosis (9). The overall 
costs of MSK to the Norwegian government were estimated to be approximately 70 
billion NOK in 2009 (10). The majority of these costs are connected to work 
disability. It has been a political issue in Norway for several years to prevent long-
term sick leave and work disability from MSK. However, the search for effective 
treatment programmes continues.   
This thesis originates from a Norwegian national project called “A Faster Return”, 
established in 2007 in specialist healthcare. The project encouraged exploring new 
strategies and approaches to help people with health problems to stay at or go back to 
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work. The Department of Physical Medicine and Rehabilitation (DPMR), Innlandet 
Hospital Trust, was included in the project and assigned the task of setting up an 
outpatient clinic for patients with MSK. 
1.2 Health 
Few would argue that health is vital to life. However, the distinction between good 
health and bad health can vary significantly between individuals and cultural systems, 
as the term relates to subjective, medical (objective) and social aspects (11). 
Population studies in the Nordic countries reveal that most people report some sort of 
illness or ongoing SHC (12, 13). The individual evaluation of health status could, 
however, differ significantly. The concept trilogy of illness, disease and sickness is 
useful for a better understanding of these differences (14). Illness refers to the 
subjective sense of ill health and ranges from minor symptoms to more severe or 
acute health problems (15). A disease refers to a condition that is diagnosed by a 
medical expert, while it possible to label a diagnosis with reference to medical 
science (16, 17). Sickness refers to the social role that an individual with illness takes 
or is given by society. The relationship between the concepts has been considered to 
be simple and totally overlapping (Fig. 1), but studies have found that they interrelate 
in a more complex manner with relatively less overlapping, indicating that they 
represent different realities (11) (Fig. 2).  
       
Hypothetical relation between illness, disease, sickness and sickness absence in two different 
models, modified from Wikman et al. 2005 (11). 
Fig. 2 Fig. 1 
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To be granted sick leave in Norway, you need to be incapable of working due to a 
medically accepted diagnosis. The definition of health according to World Health 
Organization (WHO) from 1948 is: “A state of complete physical, mental and social 
well-being and not merely the absence of disease or infirmity.” The definition has 
been widely criticized as it leaves most people unhealthy most of the time. Given the 
increasing amount of people living and ageing with chronic diseases, “complete well-
being” may no longer fit the purpose, but rather increase the risk of medicalization in 
society. Different proposals for improving the definition of health have been made in 
recent decades. The best known is the Ottawa Charter emphasizing social and 
personal resources as well as physical capacity as important aspects of health (18). 
More recently, Huber et al. suggested changing the definition to “the ability to adapt 
and self-manage in the face of social, physical and emotional challenges” (19). The 
authors claim that this definition complies better with the disease patterns and health 
challenges of today and would provide measurements of health and health policies 
more effectively than the WHO definition. 
Given the high prevalence rates of MSK worldwide, combined with the fact that up to 
85% of these conditions are non-specific, we might agree that focusing on adaption 
and self-management seems more suitable than focusing on “complete well-being” 
(20). Guidelines for the treatment of MSK underlines the importance of self-
management and adaption as they point to education, stress management, behavioural 
treatment, physical training and staying active in spite of pain problems as important 
elements (5, 20-23).  
1.3 Work and health 
Work can be potential harmful to health if the worker is exposed to physical or 
chemical hazards or occupational injuries, among other factors (24). However, many 
of these factors have systematically been eliminated, or their detrimental effect has 
been significantly reduced in modern working life through legislation and systematic 
health environment management related to work (25). In Norway, our first law 
regulating potential health hazards in the workplace appeared in 1977 (AML 1977). 
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Despite a drive to render the workplace less physically demanding, the cases of work-
related MSK has increased (26). Psychosocial aspects of work, such as the social 
organization of work, the degree of job stress, satisfaction with work, experienced job 
control, job relations and leadership, all matter to health (27). The presence of 
negative psychosocial factors increases the risk of occupational MSK (25). In a 
Norwegian survey, it was found that the majority of cases involving MSK (confined 
to the neck, shoulder and arm) were assessed to be work-related both by the study 
participants and by the experts (28).  
Work is recognized by the WHO as being one of the key social determinants of good 
health (29). In general, having a job is better for health than not having a job, as work 
has several obvious advantages. Work provides income and thus economic security. 
Work defines a social role and identity and is a source of self-esteem, as well as being 
the major source of a social life for most people and creating a structure for the day 
and the week (30).  
1.4 Sick leave and work disability 
Multiple negative effects on the life situation in general have been documented, 
especially related to leisure activities, sleep and psychological well-being (31). Sick 
leave as a treatment device could be compared to applying broad-spectrum antibiotics 
for infections; it works broadly as a general tool but with low precision. 
Subsequently, it affects the individual’s total life situation and in turn may lead to 
unintended side effects, such as reduced work motivation, social isolation, inactivity, 
changed self-esteem, economic strain and secondary health problems, particularly 
mental ones (31-33). Delayed RTW has become a critical social problem in many 
societies, affecting not only government economics but also individual quality of life 
and well-being (34).  
There is increasing evidence that, for patients with MSK, the total absence from work 
over time delays the recovery from the condition (5, 35). Additionally, the longer the 
duration of sick leave, the more difficult it is for the employee to RTW (36, 37). PSL 
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could be a way to limit the negative side effects of the absence from work (38). 
Andren et al. found that employees assigned to PSL recovered to full work capacity 
with a higher probability than those assigned to full-time sick leave (FSL) (39). PSL 
is a strategy that many employees find satisfactory (40). A review on benefits and the 
harmfulness of sick leave concluded with a call for RCTs to evaluate effects on health 
issues from sick leave (41).  
Disability can be explained as “something that restricts or limits”; when related to 
work, it is usually defined as time off work, reduced productivity or working with 
limitations due to a clinical condition (42). The term indicates a relation between 
health and work ability or functioning at work. However, the causes of work 
disability could be extend beyond health factors and frequently include psychosocial 
factors, workplace factors and personal factors, such as family matters, beliefs and 
expectations (43). Additionally, welfare systems and cultural differences contribute to 
the evaluation of work ability or disability (44). Subsequently, disability could be 
understood and explained from different perspectives, with different models of 
disability having evolved during the 19
th
 century (43).  
In the research on work disability and MSK, several non-medical factors, such as 
psychosocial and work conditions, have emerged as important (45, 46). The majority 
of studies has focused on LBP, but it is increasingly accepted that factors associated 
with disability are complex and that there are similarities across disorders (47, 48).  
1.4.1  Reasons for sick leave and work disability 
Biomedical factors 
In MSK, the aetiology in most cases is multifactorial and no specific somatic causes 
can be detected (49, 50). However, clinical guidelines recommend a thorough clinical 
examination to rule out serious pathology, such as tumour, acute inflammation or 
infection, often named “red flags”, meaning that specific treatment should be 
considered (5, 20). Pain intensity and radiating pain have been identified as a 
predictor for the duration of sick leave in some studies (51, 52). However, pain and 
disability are not always closely linked as many workers stay at work with pain and 
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health problems, a phenomenon known as “presenteeism” (3, 53). Structural findings, 
such as degenerative changes in the intervertebral discs, vertebrae or facet joints, on 
the MRI of the spinal column are common, non-specific and weakly associated with 
pain (54, 55). Although there is evidence for Modic changes in the vertebral 
endplates, which are associated with LBP, it is not clear how they influence the 
course of LBP (56). A literature review on the course of LBP concludes that 
psychosocial and belief-related factors are the most common predictors of outcome. 
This is similarly the case for acute and chronic LBP (cLBP), although most of the 
variance in outcome remains unexplained (57). Demographic variables such as 
gender and age are identified as predictors of the duration of illness in some studies 
(51, 58). However these results were not reproduced in later studies (6, 59). A recent 
review on prognostic factors for disability and sick leave in subacute pain patients 
concluded that, at an individual level, multiple site pain, older age and longer pain 
duration were potential prognostic factors for disability (60).  
Psychosocial and psychological factors  
By the term “psychosocial”, we could understand it to mean “pertaining to the 
influence of social factors on an individual’s mind (perceptions, thoughts, feelings) 
and behavior and the interrelation of behavioral and societal (cultural) factors” (61). 
Psychosocial factors are among the most important predictors of chronicity in MSK 
(46, 62-64). Psychosocial factors can influence the course of acute MSK by 
interfering in different phases of the clinical condition: at the onset of pain, on 
seeking and receiving of healthcare and other support, and in the development of 
chronic pain and work loss (62, 65). Co-morbid psychiatric disorders, especially 
anxiety and depression, are associated with the development of cLBP (46, 57). Co-
morbid depression has predicted work disability in some studies (66, 67), but not in 
others (68). Negative expectations, fear avoidance beliefs, psychological distress, 
catastrophizing and passive coping strategies have also been identified as risk factors 
for non-recovery from MSK (34, 69-72). The patient’s own expectations of recovery 
seem to be an important factor for sickness absence in cLBP (73). Personal 
experience of illness and disability and emotional reactions might also influence 
recovery (74). Former multiple episodes of sick leave can by themselves be risk 
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factors for non-RTW (75). Low education level and low socio-economic status are 
also associated with protracted courses and poorer outcomes for LBP (56, 58, 76). 
Cultural factors, such as welfare systems, labour markets and social factors also 
influence work disability and sick leave (77).  
Work-related factors 
Physical, organizational, psychological and societal aspects of work could influence 
health and increase risk of disability (30). MSK can be triggered by occupational 
factors, such as repetitive manual tasks, uncomfortable work positions, physically 
stressful work, lifting or carrying loads, and pushing or pulling loads (78, 79). High 
job demands, low control and low support at work influence the risk of MSK 
significantly (52, 80). A model of job strain was developed by Karasek in 1979, 
which introduced the factors of job demands and control over work as decisive for the 
degree of mental strain experienced (81). A job with high demands and low control 
will be characterized as the most stressful or “high strain” work with a subsequently 
increased risk of developing health problems related to work. Later on, the parameter 
social support was introduced as a modifier in the model, illustrating that support 
could dampen the negative effects of low control and high demands. However, the 
relation between physical strain and MSK is inconsistent (58). Steenstra and co-
workers identified work demands, accommodation and modified duties, and job 
satisfaction to be factors predictive of RTW for workers with LBP (59). Adverse 
psychosocial and societal work factors are associated with the development of MSK 
and with disability (46). 
Factors related to healthcare providers 
Healthcare providers (HCPs) need to be conscious that obstacles to work 
participation may exist at levels beyond somatic complaints. The identification of 
factors related to work ability should therefore be examined in a comprehensive way. 
The allotted time for each patient in primary care could be a limitation for the GP in 
this work. Additionally, HCPs are primarily educated and trained in the biomedical 
approach to illness and therefore be without the competence or experience to deal 
with complex disability cases (82). The biomedical approach could lead to 
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unnecessary imaging tests, overtreatment, more referrals and more disability (83). 
Additionally, the evaluation of work conditions is not a standard topic when HCPs 
consult patients with MSK (84). Adverse disability outcomes can be related to 
communication failures between the employee and the HCP (85). The therapeutic 
alliance influences the outcome of treatment (86). As MSK is one of the most 
prevalent health complaints in primary care, the therapeutic alliance could be 
important to outcomes. Descriptions of successful treatment interventions often cite 
improved communication as a decisive factor for success (52, 87). Prevailing models 
of disability management often rely on authoritative or unidirectional communication, 
leaving the patient (worker) in a passive role (88). Pransky and co-workers suggest 
that improvements in communication between stakeholders in the RTW process 
could be the answer to further improve disability outcomes across interventions (87). 
The implementation of communication in therapy according to a biopsychosocial 
understanding of disability could support this suggestion and improve RTW 
outcomes in patients with MSK (89). There is still a considerable influence of the 
biomedical paradigm in clinical practice (32). As most forms of MSK are non-
specific, the sick leave process becomes mainly patient-driven, although modulated 
through GPs’ attitudes, beliefs and personalities (90). 
1.5 Return to work interventions for musculoskeletal pain 
RTW can be conceptualized as 1) “the process of returning a worker to work”, for 
example through job accommodation or graduated RTW, or 2) as a measurable final 
outcome of disability: the status of working/not working (91). RTW as a measurable 
outcome has been defined in several ways: as a categorical variable (as RTW yes/no), 
a continuous variable (as time to RTW or to s-RTW) or a cumulative variable 
(duration of days lost from work) (91). Consequently, the measurements of, and 
perspectives on, RTW in clinical practice and in research vary widely (42, 45). The 
significant body of research in the field of occupational disability has unfortunately 
been hampered by this heterogeneity, and our ability to predict, understand and 
facilitate good outcomes is still limited (32, 69, 92). Early RTW research viewed 
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work status as being dependent on the severity of the clinical condition of the worker, 
with the ability to return to employment a product of the recovery process, indicating 
a linear progression of events (92, 93). Nowadays, we acknowledge that the RTW 
process is much more complex and can be viewed as one that encompasses a series of 
events, transitions and phases involving interactions with other individuals and with 
the environment (74, 77, 92). RTW interventions subsequently include a variety of 
treatment programmes and components in pursuit of improving health, reducing 
barriers to work and facilitating work participation (94). Hence, physical exercise, 
patient education, cognitive or behavioural therapy and work accommodation are 
typical treatment components in these programmes. This variety reflects not only the 
composite nature of the work disability problem, but also the lack of a unifying 
model of health and disability related to work participation (42). European guidelines 
recommend cognitive behavioural therapy, supervised exercise therapy, brief 
educational interventions and more comprehensive biopsychosocial, multidisciplinary 
interventions for cLBP patients (20). However, the effectiveness of RTW 
interventions for MSK is still debated (95). 
1.5.1 Brief interventions  
BI programmes most often refer to a cognitive and educative approach based on the 
NIM and a non-directive communication and social support (NDCSS) in addressing 
pain and fear avoidance (96). The clinical examination involves a physician and a 
physiotherapist. The essential features are a diagnostic clarification, a thorough 
educational, medical examination with reassurance offered about normal findings. A 
return to normal activity including work is recommended. BI programmes are 
effective in reducing sickness absence and short-term disability compared to 
treatment as usual (TAU) for patients with subacute LBP (96-98).  
BIs have been applied in several clinical trials in recent decades, with reviews 
concluding that BIs for patients with subacute LBP are effective in the clinical setting 
for RTW outcomes compared to no intervention, provided interventions last for a 
minimum of 2.5 hours (99). Another review found BIs to be superior to usual care in 
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terms of RTW and short-term disability (98). However, the effect on RTW and health 
outcomes for chronic back pain patients remains inconclusive.  
Non-injury model  
The NIM is based on the knowledge that MSK, including LBP, is mainly non-
specific without any objective findings or indications of damage (96, 100). The model 
was developed in the 1990s for the treatment of LBP and evolved as an alternative to 
the biomedical model of illness, as normal findings were the most frequent (96). In a 
biomedical tradition, symptoms related to LBP were assumed to be a sign of illness 
or damage associated with structural pathology (101). The underlying principles of 
the NIM are based on the evidence that the back is a robust structure and that LBP is 
not caused by any wrongdoing (100). The NIM is in accordance with the European 
guidelines for the management of LBP (20).  
Non-directive communication and social support 
Communication in the BI is based on NDCSS, which implies that the therapist does 
not value or judge the patient’s evaluations, choices or feelings, but cooperates with 
an acceptable attitude (102). The information will be provided in a non-directive way, 
to leave the patient to make conclusions and decide on their own about physical 
activity. Studies have found better compliance when NDCSS was practised than 
when applying directive support, which is far more instructive and demanding (103).  
1.5.2 Multidisciplinary interventions 
Prolonged pain tends to develop into a combination of physical and psychosocial 
disabilities and various MDIs have evolved to meet this complexity in the clinical 
picture (94, 104). An MDI generally involves different professions in the treatment 
team and treatment elements, which more frequently comply with the 
biopsychosocial model of illness (105). Nevertheless, the effectiveness of MDIs on 
RTW and clinical outcomes in MSK has repeatedly been questioned along with a call 
for high-quality trials in the field (23, 106). A review in 2008 concluded that MDIs 
represent the state of the art of the management of complex, chronic non-malignant 
pain, although there is no consensus on the content of MDIs or who might benefit 
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more from a comprehensive approach (107). Various studies have aimed to identify 
effective RTW strategies over recent decades (32). There is still a call for more 
knowledge on which treatment components could be more important for subgroups in 
the MSK patient population (107). A major problem has been the high degree of 
heterogeneity between studies, making comparisons difficult. However, a Cochrane 
review found MDIs to be more effective in decreasing pain and disability than TAU 
and physical treatments, and more effective than physical treatments on RTW 
outcomes (108). Another review looking at the effectiveness of MDIs on RTW found 
effects before TAU or conservative treatment for subacute LBP but not for cLBP 
(109).  
Several trials have compared the effects on RTW of a work-focused MDI, with the 
effects of TAU, which is frequently the treatment approach in primary care (110-
112). In the Sherbrook model, which consists of multiple elements, Loisel and co-
workers found that a workplace intervention as a component of an MDI was superior 
to a clinical intervention plus graded, physical activity over six to eight weeks, for 
RTW outcomes in patients with subacute LBP (112). Both the clinical and the 
occupational interventions were superior to TAU with a hazard ratio (HR) of 2.41 for 
an RTW. Loisel later recommended future trials to focus on intervention development 
rather than making comparisons with TAU, as it is obviously ineffective (77). Anema 
et al. replicated Loisel and co-workers’ trial in a Dutch setting and found the 
workplace intervention to be superior to TAU, while graded physical activity had a 
negative impact on work outcomes (111). RTW was defined as f-RTW for four 
weeks without partial or full drop-out from work because of LBP. Steenstra 
concluded that a workplace intervention resulted in a safe and faster RTW compared 
to a clinical intervention for workers with LBP (113). Lambeek et al. compared an 
integrated care approach involving a workplace assessment in specialist healthcare 
and TAU in primary healthcare for patients with cLBP and found a considerable 
effect of the integrated care programme on RTW compared to TAU after12 months 
(114). The primary outcome was f-RTW for at least four weeks and secondary 
outcomes were functional status and pain. Functional status was much better in the 
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case of integrated care at 12 months, but pain improvements were equal. The authors 
conclude that, in an advanced stage of work disability, integrated care is more 
effective both for work outcomes and for private life (114).  
In a review on intervention characteristics facilitating RTW, the authors concluded 
that early interventions (within six weeks) and MDIs were beneficial in addition to 
activating interventions such as a gradual RTW (115). Another review concluded that 
stakeholder participation and work modification are more effective for RTW and 
should be preferred (116). 
1.5.3 Patient education and treatment decisions in therapy 
PE has been part of clinical practice for decades now and reflects how the role of the 
patient and the role of the HCP have been going through a paradigm shift (117). For 
centuries, physicians have been allowed to overrule and interfere with patients’ 
preferences when making decisions about treatment (118). Nowadays, the clinician-
patient relationship has become more of a partnership and the patient is increasingly 
seen as responsible for their own health or recovery (119). Patient autonomy is seen 
as a basic value and underlying premise for the provision of healthcare itself (120). 
The active involvement of patients in treatment decisions requires an educational 
process involving the presentation of knowledge and information to the recipient 
(118). This educational process is of the outmost importance as it could prevent the 
unnecessary use of healthcare and enhance self-care and the use of active coping 
strategies (121, 122). There are different models of decision-making in therapy. 
Shared decision-making (SDM) is one method where the clinician and the patient go 
through the decision-making process together, consider outcome probabilities, share 
preferences of treatment and, in the end, reach an agreement on treatment choice 
(123-125). Good communication skills are vital if the patient is to understand the 
information presented to them and for the clinician to draw out the patient’s beliefs 
and preferences (125). Studies on the practice of SDM have reported improvements 
in adherence to treatment, quality of life and well-being, and in patient satisfaction 
with treatment (123, 126, 127). SDM is furthermore found to be an effective and 
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useful way to reach treatment agreements, particularly when patients have to make 
long-term decisions (118).   
Thus, the aim of PE is multifaceted: to improve the understanding of the health 
problem and treatment options, to reduce unanswered questions and concerns, to 
empower patients to take actions for recovery, and to minimize dependency on HCPs 
(128). PE is moreover a prerequisite for SDM to be practised, but PE in itself does 
not automatically induce patient involvement in treatment decisions.   
Many types of PE are used in clinical practice. Discussions with or the verbal 
delivery of information from a health professional are among the most frequent types, 
together with written content, such as a booklet or a pamphlet.  
In clinical guidelines for the treatment of LBP, PE is well integrated (49, 121). A 
review on the effects of information on LBP management concluded that information 
should be based on a biopsychosocial model, but that the delivery of information 
alone is not sufficient to prevent absenteeism and reduce healthcare costs (129). The 
Cochrane Group later reviewed the effects of PE on clinical outcomes and RTW for 
LBP and found intensive PE to be more effective for acute and subacute LBP than for 
cLBP (99). The authors found no difference in the effects of various types of PE, and 
it remains unclear what form of PE is preferred and what content, intensity and 
frequency, which is optimal. Information campaigns on the treatment of LBP on 
television have been delivered with no effect on sick leave (130). PE for patients with 
chronic MSK could be an extra challenge as patients with chronic pain frequently 
report impaired cognitive functioning with concentration, forgetfulness and attention 
problems among the most severe complaints (131-133). In a cohort of fibromyalgia 
patients without depression, cognitive impairment, particularly memory and 
vocabulary deficits, were observed (133). Visual displays may be superior to written 
text in learning and memory (134). Studies have shown that learning from graphic 
organizers are beneficial to text outlines (135). A Cochrane review concluded that 
more research is needed to find out which types of PE are the most effective (99).  
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1.6 Theories and models 
1.6.1 The biomedical model  
The models of illness that underlie our understanding of diseases and illnesses are 
rarely explicitly discussed or criticized, although they have a huge impact upon 
medical practice. The assumption that a specific disease underlies all illness has 
dominated medical thinking and practice for the past century. This model of illness 
can be referred to as the biomedical model (BMM) characterized by the following 
basic assumptions: all illness has a single underlying cause, disease is always the 
single cause and the removal of the disease will lead to a return to health (101). The 
BMM originates from Virchow who concluded that all disease can be associated with 
cellular abnormalities (136, 137). The model conceptualizes the human organism as 
being almost like a “biological machine”, while illness is a consequence of the ill-
functioning of the human organism. Disease is described as a linear sequence from 
cause factor to pathology, to symptoms or manifestations (138). Secondly, the model 
holds that symptoms and disability are directly related and proportionate to the 
severity of the biological pathology. In the BMM, the mind and body are functioning 
as separate and independent entities (139, 140). This complies with Descartes’ 
dualism of mind and body (141). The physical disorder is superior to the less 
important or secondary psychological, social and behavioural dimensions in the 
BMM (138). Fundamental to the model is the belief that the physician is responsible 
for the control and, ideally, relief of pain (105). Subsequently, communication in the 
BMM is often unidirectional and characterized by expert teaching or instructing. 
The model has intuitive appeal as it complies with our scientific thinking on cause 
and effect in a linear connection and  performs well in the case of uncomplicated 
injuries, illnesses or pain in acute stages where healing processes are predictable, as 
well as in ruling out serious pathology, such as tumours, fractures or infections (138). 
The model is supported by a vast number of biological findings related to illnesses.  
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Although the BMM has made huge improvements in medical care, it has also 
undermined the understanding and effective treatment of many illnesses in the search 
for pathologic findings.  
1.6.2 The biopsychosocial model 
Engel proposed a new model of illness where many of the shortcomings from the 
BMM were addressed (105). The single-cause, single-category and single-effect 
models of health and illness were replaced by a multicause, multicategory and 
multieffect model, known as the biopsychosocial model (BPSM). The introduction of 
the BPSM reflected a paradigm shift in science in general. Engel offered both a 
philosophy of clinical care and a practical, clinical guide when he proposed this new, 
holistic model. The BPSM has been especially influential in the area of chronic pain 
(140).  
The BPSM is based on a system approach where Engel claims that nothing exists in 
isolation. The person is experienced as integrated into a hierarchy of dynamically 
related natural systems: the cell is part of an organ and a person, a family, a society 
etc., and these increasingly complex systems are seen as interactive, interconnected 
and interdependent (Fig. 3.) (89, 105). The BPSM, when applied in medicine, 
systematically considers the interaction of biological, psychological and social factors 
in the process of understanding human health, illness and disability in the planning of 
healthcare. Engel emphasized that the patient’s story should be elicited in the context 
of life circumstances and the clinician should determine which aspects of biological, 
psychological and social domains are the most important to understand; furthermore, 
the clinician should provide a multidimensional treatment (142). Ten years after 
Engel presented the BPSM, Waddell developed an approach to LBP, which was in 
compliance with the BPSM (49). The BPSM influences how clinicians approach 
patients while moving towards an egalitarian patient-therapist relationship (85). In the 
case management model, which is based on the BPSM, the patient is an active 
participant in the rehabilitation process, while the rehabilitation team facilitates the 
process, reflecting the shift from the HCP-patient relationship, to a multiplayer-
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decision maker system, which is influenced by multiple interacting systems (77, 138). 
The BPSM has been criticized for not clarifying person-environment interaction in 
relation to the implications for RTW and conception of work ability; more precisely, 
how natural systems including the work arena influence a person’s decisions about 
their own work ability or work participation (93).  
 
Fig. 3 The biopsychosocial model (Engel 1977). University of Rochester Medical Education 
 
1.6.3 International Classification of Functioning, Disability and Health 
The International Classification of Functioning, Disability and Health (ICF) was 
approved as an international tool for describing and measuring function, health and 
disability by the World Health Assembly in 2001, replacing the outdated International 
Classification of Impairment, Disability and Handicap (ICIDH) (143, 144). The ICF 
provides a complex understanding of health and disability in line with the BPSM, 
including biological, individual and social aspects (145). Before the ICF, health was 
conceptualized as the opposite of disease or death, and traditional health indicators 
had typically been related to mortality or morbidity. Disability was seen more as an 
unrelated entity, as bodily impairments, such as blindness, restricting or limiting the 
individual in their capacity to take part of daily life activity. The ICF brought these 
concepts together into a comprehensive description of the multiple dimensions of 
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human functioning. The ICF has been widely utilized ever since and implemented in 
various settings and sectors, with rehabilitation medicine as a dominant arena (146, 
147). A disability process initiated by a health condition is, according to the ICF, 
influenced by both environmental factors and personal factors (Fig. 4). The 
environmental factors include societal attitudes and beliefs, welfare systems, the 
workplace as well as climate or terrain, while personal factors include age, gender, 
beliefs, personality, previous experience, coping strategies and education. The BPSM 
is thus embedded in the ICF, describing how medical, individual, social and 
environmental factors mutually influence functioning and disability.  
The ICF represented an important step forward from the ICIDHS in the 
understanding of health and functional ability. The model has however been criticized 
for not being based on theory and for not justifying the BPSM as the underlying 
model (148). Additionally, work factors have not been specified in the model. 
Herrkens and co-workers developed a supplemental model to describe work-related 
factors influencing the health of employees, to fill the terminology gap between 
professionals in healthcare and in occupational medicine (149).  
 
Fig. 4 The ICF model: Interaction between ICF components (WHO 2001) 
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1.6.4 Cognitive activation theory of stress 
The cognitive activation theory of stress (CATS) offers a model of understanding 
how stress and coping are related to health (150). The principles of the model are 
transferable to the field of sick leave as it presents an explanation, at an individual 
level, of how the process of coping/non-coping might affect health and influence 
lifestyle choices through learning (151). Learning is defined either as stimulus 
expectancy or response outcome expectancy. The CATS describes how the 
individual, based on available reinforcement contingencies and resources, learns 
positive outcome expectancy (coping) or negative outcome expectancy (helplessness: 
that nothing matters whatsoever; or hopelessness: that everything goes wrong) (152). 
The “load” (stressor) could be any stimulus that is either new or not as you expected 
it to be (stimulus expectancy). The response to the load is an arousal (stress 
response), which initiates a cognitive processing of the information (150). The stress 
response proceeds in one of two possible pathways; either producing a short anabolic 
response with no pathophysiological effects (train effect) or producing a sustained 
catabolic response that may have adverse health effects (strain effect). Positive 
feedback or feedforward mechanisms enhance learning and produce expectancies 
formed by previous experiences. A positive outcome expectancy (coping) is the 
expectation that most or all of your actions will produce the desired outcome. When 
coping fails, negative expectancies, either helpless or hopeless, are acquired. These 
expectancies could lead to poor health through highly sustained arousal, which can 
cause somatic changes (153). However, negative expectancies may also lead to poor 
health through a learning mechanism, where the development of helplessness or 
hopelessness affects the motivation to make life changes. A helpless individual is less 
likely to develop and comply with advice about new behaviours as they have learned 
to believe that there are no relations between actions and reward. An individual 
experiencing hopelessness is even more susceptible to this, as they expect that 
everything they do produces a negative outcome. The cognitive brain mechanisms 
that determine the choice of behaviour follow the rules of learning theory: what 
expectancies of outcome have been learned, what the rewarding factors for the 
individual are, what the chances of success are, and how much energy is to be 
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invested in a particular behaviour. This also means that response outcome 
expectancies could change with new learning experiences that modify the original 
expectancy. 
The CATS offer an explanation as to why focusing on individual coping is so 
important in the treatment of patients suffering from chronic MSK. However, the 
CATS have been criticized for overestimating the power of the individual and the 
environment in the course of forming behaviour (154, 155).  
 
Fig. 5 Schematic presentation of CATS, adapted from Eriksen et al. (2005) 
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2. Overall aims and research questions 
The primary aim of the study was to clarify whether MI can improve RTW rates 
within two years over BI in patients on sick leave with MSK. Secondly, we sought to 
identify predictors for s-RTW and, lastly, compare patient health, functional ability 
and coping between groups during 12 months of follow-up.  
These aims will be addressed by three different research questions corresponding to 
the aims of the three different papers: 
Research question 1 
Can a comprehensive, educational approach, i.e., the MI, with a particular focus on 
psychosocial factors and work situation, improve RTW rates for patients on sick 
leave due to musculoskeletal complaints, before a BI?  
Research question 2 
Is s-RTW, defined as increased work participation in three consecutive months, at 
three and 12-month follow-up, predicted by patient health factors, functional ability, 
work-related factors or by interventions? 
Research question 3 
Is a comprehensive, educational approach, i.e., the MI, with a particular focus on 
psychosocial factors and work situation, more effective in improving patient health, 




3. Design, material and methods 
3.1 Design and study population 
This study was an RCT involving sick-listed patients referred to DPMR, Innlandet 
Hospital Trust, Norway. The study was carried out in the same department. The 
planning of the study started in 2009 and patients were included in the trial until 
December 2012. Follow-up was 12 months for health and 24 months for work 
parameters.  
 
A total of 534 patients with MSK and referred to the DPMR were considered for 
inclusion in the study. Among these, 284 patients (54% women, mean age 41.3 years) 
were included and randomized to either MI (n=141) or BI (n=143). The patients were 
referred from their GP in 48 municipalities in two counties in the south-eastern part 
of Norway. The GPs had no information that there was a possibility that their patient 
would be included in a clinical trial.  
 
The following inclusion criteria were applied: age 20-60 years, at least 50% sick 
leave due to MSK for up to 12 months and at least 50% employed. The exclusion 
criteria were: pregnancy, current cancer, osteoporosis, recent physical trauma/injury, 
serious mental illness, rheumatic inflammatory diseases, not capable of understanding 
and speaking Norwegian, being involved in a health insurance claim. Of the 534 
patients considered for inclusion in the trial, 250 were either not eligible or excluded 
for different reasons.  
3.2 Context 
In Norway, all lawful residents are included in the Norwegian public insurance 
system. This system provides health service benefits and pensions to all members, 
and payments are administered by the Norwegian Labour and Welfare Administration 
(NAV). Sick listing is usually provided by the GP and requires a medically 
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acknowledged disease. If an employee has been in work for the last four weeks 
before the sickness incident, they are granted 100% of the ordinary salary in sickness 
compensation from the first day of the sickness absence and up to one year. The 
employer covers the first 16 days; thereafter the NAV covers the disbursement. Sick 
leave can be graded from 20% and up to 99%. After one year, the patient can apply 
for further benefits if they have not yet returned to work. These benefits come under 
the name of Work Assessment Allowance (WAA) and constitute approximately 66% 
of the patient’s former income. WAA can be combined with work if the disability 
constitutes a minimum of 50%. WAA is granted with an upper limit of four years, 
provided that the patient is going through medical rehabilitation or treatment or is 
involved in any type of vocational rehabilitation. Patients in this study were on sick 
leave, either fully or partly, when entering the study; they were also able to convert to 
WAA during the follow-up. WAA could be fully or partly received (with a minimum 
of 50%) and combined with work activity.  
3.3 Sample size 
The sample size was calculated before the study and based on data from another RCT 
study on RTW (97). The calculation was based on transition probabilities calculated 
for the intervention group in this study, using standard formulas for calculating 
sample sizes for studies comparing binominal proportions. Provided a power of 80% 
and a significance level of 5% are achieved, the number of patients in each 
intervention group of our study was estimated to be 150, giving n=300 for this study. 
3.4 Procedures and interventions 
Both intervention groups received their treatment at the DPMR, Innlandet Hospital 
Trust, but the location of treatment sessions and the treatment teams was different. 
The HCP performing the BI was experienced in the method and had recently been 
audiotaped performing a BI in another clinical trial (156). The HCP providing the MI 
had received some training in the method in beforehand, and, during the study, they 
had regular meetings to ensure the equal practice of the method. For practical 
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reasons, there was no blinding to treatment among the therapists or participants. After 
inclusion, informed consent was obtained from each participant and allocation was 
made to a treatment group, while a letter with the date of the baseline treatment 
intervention was sent to the participants together with a set of questionnaire. In a 
cover letter, the patient was requested to answer all questions and bring their 
responses to the appointment at the clinic. Later on, the patients received a 
questionnaire at the three- and 12-month follow-up. Patients who dropped out of 
treatment were asked if they were willing to continue filling out the questionnaire and 
return it by mail.  
3.4.1 Randomization  
The randomization was concealed and all patients were randomized to either the MI 
or the BI according to a computer-generated randomization list set up by a statistician 
at Uni Research Health (URH). A research assistant at the DPMR assigned each 
study participant an ID number after inclusion and informed consent was given by the 
participant. URH was informed of the ID number, gender, age and diagnosis. The 
research assistant then received information from URH via a telephone randomization 
system about which treatment group the patient should be allocated to. Treatment 
started as soon as possible after randomization with a maximum delay of two weeks 
due to a waiting list being in operation.  
3.4.2 Interventions 
Brief intervention 
A BI is a standardized, cognitive intervention; and, in this study, we applied the BI as 
described in the study by Molde Hagen (97), which represents a modified and less 
resource-demanding version of the BI applied by Indahl in his pioneering work on the 
method (96). Treatment manuals were written and based on current guidelines and 
the manual used by Hagen (20, 97).  
 
Baseline assessment: At the baseline consultation, the patient first met a physician for 
about an hour and then a physiotherapist for about 1.5 hours. The session with the 
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physician, who was a specialist in physical medicine and rehabilitation, included time 
for the patient to express problems and concerns/worries, followed by a thorough, 
clinical, educational examination by the physician for the purposes of diagnostic 
clarification. Any somatic findings were explained and their significance was related 
to the actual problems, while normal findings were explained in a positive way. If the 
patient had any X-rays, the radiographs were shown and explained. In the absence of 
symptoms and clinical findings indicating serious disease, the patient was informed 
about the good prognosis and the importance of staying active and returning to 
normal life, including work, as soon as possible. The patient was encouraged to take 
daily walks and reassured that light activity would be beneficial and do no harm. The 
following consultation with the physiotherapist comprised a physical examination 
related to the pain problem. The physiotherapist could draw attention to unfavourable 
movement patterns, muscle tension or other findings, and advise the patient on 
exercises, stretching or giving practical advice for coping at home and in the course 
of daily activities.  
 
Two-week follow-up: The follow-up consultation with the physiotherapist after two 
weeks typically lasted one hour. At this consultation, advice and instructions given at 
the baseline session were evaluated, while the patient could discuss relevant issues of 
importance with the physiotherapist. Written reports from the consultations were 
routinely sent to the GP after each consultation, with a copy issued to the patient. 
Multidisciplinary intervention  
An MI represents a novel, cognitive approach; in this case, the method had been 
worked out in cooperation with therapists at the DPMR during the “A Faster Return” 
project. The MI involved three therapists in the treatment team, a social worker, a 
physician and a physiotherapist. The method assessed specific psychosocial and 
work-related factors and applied a new visual communication tool, namely, the 
Interdisciplinary Structured Interview with a Visual Educational Tool (ISIVET). The 
purpose of the ISIVET is to strengthen communication and education in therapy and 
improve patient engagement in rehabilitation. The MI involved more treatment time 
with one extra consultation and one extra therapist in the team. Written treatment 
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manuals were applied, with a detailed description of the content of the different parts 
of the method. Treatment was based on current guidelines and otherwise 
individualized due to the ISIVET process. 
 
Baseline assessment and ISIVET: The patient consulted with members of the 
treatment team (a social worker, a physician and a physiotherapist) successively. 
Each therapist had a specific assignment at the meeting with the patient:  
1) The social worker provided a survey of the patient’s family life, education, 
finances and work. A star plot named “Work conditions”, which is part of the 
ISIVET, was filled in.  
2) The physician completed a general medical journal with a thorough physical 
examination, concluding with a diagnosis according to ICD-10 (17). An 
educational, physical examination of the patient was performed, in which 
eventual findings and their relevance to the pain problem was discussed. 
Normal findings were addressed and discussed in a positive way, as in the BI. 
A star plot named “Quality of life”, which is part of the ISIVET, was filled in.  
3) The physiotherapist assessed the musculoskeletal problems of the patient and 
made a physical examination related to the pain problem. The physiotherapist 
was able to call attention to unfavourable movement patterns, muscle tension 
or other findings and advise the patient on exercises, stretching or giving 
practical advice for coping at home and in the course of daily activities.  
The ISIVET comprised a manual for filling out two star plots (Appendix 1) for 
“Work conditions” and “Quality of life” and a table for creating an individual 
rehabilitation plan. Each star plot had seven axes, representing a parameter relevant to 
the actual issue. The star plot for “Quality of life” mapped physical complaints, 
psychological well-being, sleep, energy, physical activity level, social participation 
and occupational participation. The star plot for “Working conditions” mapped work-
related stress, satisfaction with job tasks, work load, collegial relationships, 
leadership, degree of challenges at work and occupational participation. The scores 
were set between 1 and 10 where “10” was positioned on the periphery of the axis, 
indicating an optimally positive situation, whereas “1” was located close to the origin, 
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indicating a maximum negative situation. The patient and the therapists used a 
manual with illustrative examples of situations at different levels and, through 
discussion, identified the right score for the patient. When all scores were completed, 
a line was drawn between the seven scores, creating an area in each of the two star 
plots. The area under the lines was coloured to allow for better visualization for the 
patient as well as for the therapists. Problem areas or challenges were demonstrated 
by a lack of colour, while existing resources stood out as coloured areas.  
 
When the sessions with the three different therapists were completed, the whole team 
met briefly to share findings and discuss possible barriers to work participation. The 
patient joined the meeting to a final discussion with the team about their situation, 
health problems and work situation. The two star plots were central in this summing-
up phase and informed a discussion with the patient about possible actions. The 
patient played a major role in this phase by deciding on how to move forward, with 
reference to the star plot areas. An agreement on actions was written down, which 
also comprised the patient’s rehabilitation plan. Actions were typically related to the 
cognitive assessment of health and pain, lifestyle, family and work matters. Efforts to 
increase physical activity on a daily basis were typical. When leaving the clinic, the 
patient received a paper copy of the star plot with the coloured areas and the 
rehabilitation plan listed as points to be followed. The complete baseline assessment 
lasted 3.5 hours.  
 
Two-week follow-up: The patient and the physiotherapist met for one hour to evaluate 
the rehabilitation plan and work through the two star plots in the ISIVET once more. 
New scores and new areas on the star plots were coloured with a new colour. The 
visualization of area changes in the star plots was a matter of attention and reflection. 
Previous advice and actions were highlighted accordingly, and adjustments in the 
rehabilitation plan were eventually made.  
 
Three-month follow-up: The patient met with the whole team for one hour to review 
the situation and evaluate the interventions so far. The two star plots in the ISIVET 
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were worked on once again, with areas on them coloured with a third colour. 
Eventually, they adjusted the rehabilitation plan.  
 
12-month follow-up: The physiotherapist contacted the patient by telephone to work 
out the ISIVET in order to obtain a final measurement and not to evaluate the 
situation. This involved brief contact lasting about 15 minutes.  
3.5 Therapists 
The patients received their treatment at two different outpatient clinics at the DPMR, 
Innlandet Hospital Trust. A physician who was specialist in physical medicine and 
rehabilitation and a physiotherapist delivered the BI. A written manual was used. 
Both therapists were experienced in the method. 
Four physicians, all specializing in physical medicine and rehabilitation, two social 
workers and four physiotherapists delivered the MI. The team members were the 
same during the treatment course of one patient. The ISIVET was originally 
developed by the first author (RB), but was further developed and adjusted at the 
DPMR during the planning stage of the study. To ensure adherence to the protocol 
and equal practice of the method, the MI teams held regular meetings for supervision 
and discussion.  
3.6 Instruments  
Demographic baseline questionnaire 
The comprehensive questionnaire at baseline comprised demographic variables, 
information on education and different aspects of work, self-ratings on health, fitness 
and physical activity, information related to the sick certification, and the duration 
and initial/actual extent of sick leave. The following clinically validated questions 
were applied: 
The Subjective Health Complaints Inventory (SHC) is a reliable instrument for 
measuring somatic and psychological complaints over the last 30 days using 29 
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questions rated on a four-point scale (from “0” to “3”) (157). The instrument has five 
subscales: “musculoskeletal complaints” (eight items), “gastrointestinal problems” 
(seven items), “pseudoneurological problems” (seven items) and “flu” and “allergy” 
symptoms (seven items in total), in addition to a total score (SHC total), with the 
maximum value of 87 indicating the highest possible level of complaints that can be 
measured by this instrument. The subscale “musculoskeletal complaints” 
correspondingly has a maximum value of 24. 
The Hospital Anxiety and Depression Scale (HADS) assesses anxiety and depression 
disorders (158). The scale consists of 14 items that create subscale scores for anxiety 
(seven items) and depression (seven items). The total score for each subscale is 
calculated by adding the scores of the individual items (0-3) and ranges from 0 (good) 
to 21 (poor). 
The Hopkins Symptom Checklist-25 (HSCL-25) measures psychological distress 
(159). The instrument consists of 25 questions recording the presence and intensity of 
the most common symptoms of anxiety, depression and somatization. Severity is 
scored on a four-point Likert scale from 1 (“not at all”) to 4 (“very much/to a severe 
degree”), with a mean score <1.75 within normal range, while a score ≥1.75 indicates 
psychological distress in need of treatment.  
The Norwegian Function Assessment Scale (Norfunk) measures physical functioning 
(160). The instrument records different aspects of physical and psychological 
functioning with 41 questions. The questions on physical function are related to the 
patient’s ability to walk/stand, to hold/pick, to lift/carry, and to sit. The questions 
related to psychological function cover the ability to cope, to communicate with 
others, and to look/listen. The questionnaire covers the function in different activities 
undertaken during the last week and the answers are scored on a four-point Likert 
scale from 0 (“no problems”) to 3 (“not able to do the activity”). 
The Eysenck Personality Questionnaire-Nordic (EPQ-N) is a 12-item true-false 
questionnaire measuring neuroticism as a personality trait. The maximum score of 12 
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indicates a high degree of neuroticism. EPQ-N is derived from the 90-item EPQ 
(161), which measures neuroticism, psychoticism and extroversion.  
The Chronic Pain Acceptance Questionnaire (CPAQ) is a 20-item assessment 
divided into two subscales: pain willingness (nine items) and activities engagement 
(11 items). The scores are set according to a numeric scale from “0” to “6” (highest 
degree of willingness or engagement), with the CPAQ sum having a maximum score 
of 120, indicating the highest possible level of willingness to tolerate pain and engage 
in activities measured by this instrument (162).   
Physical burden of work and psychological burden of work were assessed by the 
question, “Do you experience your work as a physical (correspondingly 
psychological) burden?” The three possible answers (yes, no or some) were 
dichotomized into “yes/some”=1 and “no”=0.  
Support at work was measured by six items from Theorell, while answers were given 
using a four-point numeric scale from minimum support to highest degree of support 
(“1” to “4”), with a maximum score of 24, indicating high support at work from 
leaders and colleagues (163).  
Burden of work was measured using the demands/control fraction of Karasek and 
Theorell (163), including questions on job demands (five items) and on job control 
(decision latitude). The job control scale is the sum of two subscales: skill discretion 
(four items) and decision authority (two items). The answers are given in the range of 
1 to 4, where “4” represents the most burdensome situation. 
The Numeric Rating Scale (NRS) was applied to measure mean pain during activity, 
mean pain during rest and mean pain at night during the last 14 days. The severity of 
pain was scored on a scale from 0 to 10, with 0=“no pain” and 10=“worst possible 
pain”. 
At 12 months, the patients were asked about changes in MSK, coping with pain, 
satisfaction with treatment and the use of healthcare services outside the trial: 1) How 
are your complaints now, compared to one year ago? 2) If you still have MSK, how 
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do you cope with it now, compared to one year ago? 3) How has this project 
influenced a) your ability to take care of your own health, b) your ability to cope with 
complaints, c) your health in general, d) your physical fitness and e) your complaints? 
The answers were scored on a five-point Likert scale from “much better”=1 to “much 
worse”=5. Patient satisfaction with treatment on the project was assessed on a seven-
point Likert scale from “very satisfied”=1 to “very dissatisfied”=7.  
Cause of the pain: The study participants were asked about what they believed was 
the cause of the pain problem, with the possibility of choosing a specific cause (e.g., 
actual work, strain at home, injury, leisure activity, incorrect treatment, deformity of 
the body or just “don’t know”). 
3.7 Statistics 
In all three papers, a statistical threshold of p<0.05 was considered to be statistically 
significant. Precision was assessed using a 95% confidence interval (CI) and standard 
deviation (SD). The statistical analyses in Papers I-III were performed using SPSS 
versions 21 and 23 for Windows, IBM Corporation, Stata versions 11 and 12, and 
SAS statistical software version 9.2 (SAS Institute).  
Paper I 
Register data were used to define the work/social insurance status in each calendar 
month after inclusion on the trial. The register data provided follow-up information 
on every participant in both treatment groups for the 24-month follow-up, as well as 
information on the GP diagnosis that led to sick certification at baseline.  
Due to the inclusion criteria, all participants were employed and on sickness benefits 
at baseline. We defined that, if more than 50% of the working days in a given 
calendar month were spent on FSL, the status for that month was given as “out of 
work” (OOW). If more than 50% of the working days in a given calendar month were 
spent on PSL, the status for that month was given as p-RTW. If no benefits were 
provided in more than 50% of the working days, the status for that month was f-
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RTW. From these data, we constructed a file where each study participant had one of 
three possible statuses each month for the 24-month follow-up: OOW, p-RTW or f-
RTW. Then the monthly proportions of p-RTW and f-RTW were divided by groups 
and presented graphically on a monthly basis for the 24-month follow-up. 
Additionally, we performed multinomial logistic analysis to explore the relative risk 
(RR) ratios for p-RTW and f-RTW between the groups every month. The analyses 
adhered to the intention-to-treat principle including all randomized patients 
irrespective of compliance.  
Paper II 
In this paper, analyses for predictors of s-RTW on an individual level were 
performed. s-RTW was defined as increased work participation, compared to 
baseline, in three consecutive months. National register data were used to define the 
work/social insurance status for every study participant at baseline and in each 
calendar month after inclusion on the trial. In every month of the follow-up period, 
each participant was either out of work, partly working or fully working. At baseline, 
due to inclusion criteria, they were either out of work or partly working. The status of 
every follow-up month was compared with the status in the baseline month for every 
participant, with a “success month” defined as a month with increased work 
participation compared to the baseline, while a “non-success month” was a month 
with unchanged or decreased work participation compared to the baseline. If a person 
had three consecutive “success month” statuses, it was defined as an s-RTW, with the 
first out of the three months defined as the RTW month.  
Baseline questionnaire data were used in the analyses. The interventions were 
included as study factors as we hypothesized that the MI and the BI could have 
different effects on work outcome. The odds of s-RTW within three and 12 months, 
respectively, were analysed using binary multiple logistic regression models, 
including the following a priori selected, independent variables: 1) The interventions 
(MI=1, BI=0) and the following variables from baseline questionnaires, dichotomized 
by splitting the median score (above median score=1, median score and below=0): 2) 
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SHCs (SHC total scale), 3) anxiety and depression sum score (HADS), 4) neuroticism 
(EPQ-N), 5) acceptance of chronic pain (CPAQ), 6) muscular pain (SHC 
musculoskeletal subscale), 7) support at work and burden of work (Karasek and 
Theorell). Furthermore, the following variables, which were dichotomized to either 
yes or no by the given answers, were also included in the model: 8) physically 
demanding work, 9) psychologically demanding work, 10) whether the study 
participant believed that work was the cause of the pain and 11) duration of sick leave 
by baseline (categorized into: 0-91; 92-153; 154-213; and 214-365 days). Cronbach’s 
alpha was calculated for all scales. 
For adjustment, the models also included sex and age (20-29; 30-39; 40-49; 50-60 
years). Each predictor variable was assessed for interaction with the intervention in 
the models according to hierarchical elimination. The models’ goodness of fit was 
tested by the Hosmer-Lemeshow test. 
Paper III 
Changes in participant’s scores on depression, anxiety, somatization (HADS and 
HSCL), function level (Norfunk) and health complaints (SHC) was evaluated within 
each group by paired samples t-tests comparing three- and 12-month follow-up scores 
with baseline values. The effect size for the change, i.e., Cohen’s d for paired values, 
was assessed. A mixed between-within subjects analysis of variance, with one 
between the group factors (MI versus BI) and one within the subjects/repeated 
measures factor (baseline, three months, 12 months), was conducted to assess the 
participants’ scores in relation to the clinical variables. The interaction effects (time 
by group) were calculated and, when significant, such interaction effects indicated 
different time courses for the two interventions. Interaction effects were followed up 
by t-tests for paired samples within each group. Cohen’s d was calculated between 
baseline and the three-month follow-up and baseline and the 12-month follow-up 
using an online calculator (http://easycalculation.com/statistics/effect-size.php) based 




 )/2). Differences in outcomes between the 
two interventions, in terms of scores for pain measured by the NRS (0-10), were 
analysed by a t-test for independent samples at three and 12 months. Differences in 
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outcomes, in terms of the use of health services, patient-evaluated health changes, 
coping, and satisfaction with treatment at 12 months, were assessed with x
2
 statistics 
or Fisher’s exact test.  
3.7.1 Register data 
Register data were used to define the work/social insurance status in each calendar 
month after inclusion on the trial. The social insurance register provides information 
about the start and stop dates for payments of sickness benefits, rehabilitation 
benefits, disability pensions and unemployment benefits. For payments of sickness 
benefits and disability pensions, we have information about the degree of disability 
and hence, indirectly, the degree of work participation. Only payments for absences 
exceeding 16 days are refunded by the national insurance system. Therefore, 
absences that last 16 days or less are not included in our data.  
3.8 Ethical approval  
The study followed the Helsinki Declaration and was approved by the Norwegian 
Regional Ethics Committee in South-eastern Norway (REK 2009/1128) and by the 
Norwegian Social Science Data Services (ref. 12-4845-3). Participants gave their 
informed consent by signing the declaration of voluntarily participation before 
joining the study. 
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4. Summary of results: overview of papers 
The results are given as a summary of papers. All analyses are derived from the same 
study population of 284 individuals on sick leave with MSK and referred to a 
specialist outpatient clinic. After inclusion on the study, the patients were randomized 
to either the MI or the BI. The patients received questionnaires at baseline, and at 
three- and 12-month follow-ups. Follow-up on clinical data was set for 12 months, 
follow-up on registry data was set for 24 months. A flow chart for the study is 
available in Paper I.  
4.1 Paper I 
Randi Brendbekken, Hege R. Eriksen, Astrid Grasdal,
 
Anette Harris, Eli M. Hagen, 
Tone Tangen 
Return to work in patients with chronic musculoskeletal pain: multidisciplinary 
intervention versus brief intervention. A randomized clinical trial  
Journal of Occupational Rehabilitation (published online February 2016) 2017; 
27:82-91 
The aim of the first paper was to clarify whether the MI could improve RTW rates 
over the BI in patients on sick leave and referred to specialist healthcare due to MSK. 
RTW outcomes were analysed from register data.  
We hypothesized that a comprehensive intervention focusing on psychosocial factors 
and work in addition to somatic complaints would lead to faster RTW than a shorter 
treatment focusing on somatic complaints alone in patients with MSK. We also 
hypothesized that the application of the ISIVET educational communication tool 
would improve patient education and engagement in the rehabilitation process, 
thereby improving RTW outcomes in the MI group.  
Of the 534 patients screened for eligibility, 284 patients were included and 
randomized to MI (n=141) and BI (n=143). The mean duration of sick leave by 
inclusion was 147 days (SD=60.1). The register data received after the 24-month 
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follow-up of the last patient revealed that the study population by baseline constituted 
51 different diagnoses prescribed by the GPs (Table 1), with the musculoskeletal 
group (L-group) representing 83.9%. Register data were analysed at group level and 
on a monthly basis. Data were differentiated into p-RTW and f-RTW and OOW by 
the 24-month follow-up. Patients could be either PSL or FSL by inclusion according 
to the inclusion criteria. The differentiation made it possible to analyse the RTW 
process in more detail.  
There was a higher probability of p-RTW in the MI group during the first months of 
follow-up. There were equal probabilities of f-RTW between groups during the 24-
month follow-up. By 12 months, 44.7% in the MI group and 44.8% in the BI group 
were f-RTW. At 24 months, the corresponding numbers were 42.6% and 36.6%.  
The results show that the MI to a limited degree speed up the RTW-process and the 
effect can be explained by the increased use of PSL in the MI group. However, the 
MI could not improve RTW over the BI by the 12- and 24-month follow-up.  
Fig. 5, which is not published in any of the papers, is added below to illustrate the 
drop in the OOW proportion of the MI group during the first months of the study.  
 
 
Table 1. Sick leave diagnosis prescribed by GPs at baseline derived from registry data 
 
Diagnosis ICPC code n valid % 
LBP L02/L03/L84/L86 109    38.4 
Neck pain L01/L83 34   12.0 
Widespread pain, 
Fibromyalgia 
L18 29       10.2 




L9, L11, L12, L13, L15, L17, L19, L20, L29, L80, 
L81, L87, L89, L90, L93, L94, L99 
44     15.5 
Psychiatric P01, P02, P06, P29, P76, P81 14 4.9 
Non-specific A01, A04, A11, A80, A82 12 4.2 
Neurologic N01, N05, N29, N79, N80 11 3.9 




Fig. 5 Descriptive statistics on OOW proportions for the MI group and the BI group (BI) for each of  
           the 24-month follow-ups 
 
The data on PSL and FSL in this paper were analysed on a monthly, group-level 
basis, meaning we had no opportunity to know whether the same participants were on 
PSL, on FSL or OOW from one month to another. Nor did we have any information 
on whom might benefit from which intervention. To meet these limitations, we 
planned to analyse for predictors and to implement an RTW definition of sustainable 
work participation. 
4.2 Paper II 
Randi Brendbekken, Arild Vaktskjold, Anette Harris, Tone Tangen 
Predictors of return to work in patients on sick leave with chronic 
musculoskeletal pain 
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The aim of this paper was to identify individual baseline predictors for an s-RTW, 
while including the MI and BI as study factors to see if interventions had any 
predictive effect on work outcomes. Additional baseline independent study factors 
were: physical and psychological symptoms, including pain, anxiety/depression and 
beliefs, in addition to work-related factors and duration of sick leave by inclusion.    
s-RTW was defined as increased work participation in three consecutive months with 
the first month as the RTW month. This definition also valued any increase in work 
participation, which is in line with Norwegian official health policy. Sustainability 
could be regarded as an outcome quality control and also be helpful in answering the 
second hypothesis.  
The odds ratio (OR) of s-RTW was analysed at three- and 12-month follow-ups using 
a binary multiple logistic regression model. s-RTW was predicted by the MI at the 
three-month follow-up (adjusted OR=2.69, 95% CI=1.1-6.8) but not at 12 months 
(OR=1.13, 95% CI=0.7-1.9). The subgroup reporting low support at work benefited 
more from the MI than the BI (OR=4.2, 95% CI=1.2-14.2) and was the only study 
factor interacting significantly with the intervention. s-RTW at three months was 
predicted in the group who believed work was the cause of the pain irrespective of 
the treatment group (OR=2.17, 95% CI=1.1-4.3), while anxiety/depression was a 
negative predictor for s-RTW (OR=0.45, 95% CI=0.20-0.98). At the 12-month 
follow-up, the only factor predicting s-RTW was the duration of sick leave by 
baseline, which was a risk factor (OR=0.63, 95% CI=0.05-0.08). 
The results show that patients who receive an MI are more prone to increase their 
work participation sustainably during the first months of the follow-up compared to 
the effect of a BI. Subgroup analyses revealed only one group to have benefited more 
from MI, but the OR had a broad CI and the outcome should be interpreted with 
caution. Generally, few predictors of s-RTW were identified in a fully adjusted 
model. Symptom burden or cognitive assessment of pain or neuroticism did not 
predict s-RTW, but anxiety and depressive symptoms and length of sick leave were 
identified as risk factors for s-RTW. Patients who believe work is the cause of the 
pain benefited from both the MI and the BI, possibly indicating that the interventions 
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are equally effective in treating fear avoidance for work. No other work-related factor 
predicted RTW. 
The major finding that MI predicts s-RTW at three but not at 12 months should be 
assessed, together with the development of other secondary outcomes, such as health 
and coping, in order to proceed further in the direction of understanding this finding. 
4.3 Paper III 
Randi Brendbekken,
 
Anette Harris, Holger Ursin, Hege R. Eriksen, Tone Tangen 
Multidisciplinary intervention in patients with musculoskeletal pain: a 
randomized clinical trial 
International Journal of Behavioral Medicine (published online April 2015) 
2016; 23:1-11 
The aim of this paper was to compare and evaluate the development in patient health, 
functional ability and coping between an MI and a BI treatment group among patients 
on sick leave with MSK during the 12-month follow-up. 
We hypothesized that a more comprehensive intervention, which focused on 
psychosocial and work-related factors, in addition to somatic complaints, would help 
to identify factors relevant to the health problem and the sick leave both to the patient 
and to the treatment team. We also hypothesized that the application of the ISIVET 
would improve outcomes through enhanced patient education and involvement in 
treatment decisions, thereby improving adherence to the rehabilitation plan.  
The return of the questionnaires dropped from 98% in both groups at baseline to 79% 
in the MI and 63% in the BI at three months and subsequently 60% and 61% at 12 
months. Treatment drop-out was low in both groups.  
By the 12-month follow-up stage, the groups showed almost equal improvement in 
physical symptoms, psychological symptoms and physical functioning with mainly 
medium-sized Cohen’s d. By the three-month follow-up stage, the improvements 
were stronger in the MI group for some of the clinical variables. The recovery 
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process was analysed and significant interaction effects were found in the case of 
anxiety, depression, somatization and functional ability, indicating different time 
courses in improvements in these outcomes. There were no differences in 
improvements in SHCs and pain between groups. The MI group reported 
significantly less use of GPs in the last three months compared to the BI group, both 
at three and 12 months, while the groups made equal use of other health services, 
such as physiotherapists and chiropractors. At 12 months, the MI group reported a 
significantly better perceived ability to cope with health problems, better physical 
fitness and higher satisfaction with treatment compared to the BI group.  
The differences between outcomes in the treatment groups follow a similar pattern in 
this RCT. The differences are mainly limited to the first months of follow-up, with 
the MI group seeming to have stronger effect from the intervention, but the effect 
sizes are small to modest. At 12 months, the groups are equalized with the exception 
of some outcomes in the MI group, which we could relate to coping.  
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5. Discussion 
The main purpose in this PhD project was to investigate whether an MI can improve 
RTW rates more than a BI within two years among patients on sick leave with MSK. 
The second aim was to identify predictors for s-RTW after three and 12 months, as 
well as compare patient health, functional ability and coping between groups at the 
12-month follow-up. 
The MI improved RTW rates compared to the BI within 12 months. The effect was 
small, temporary and explained by increased use of PSL during the first seven months 
in the MI group. The effect represented a sustainable increase in work participation. 
There was no difference between groups for RTW at 12 and 24 months.  
The MI group improved faster than the BI group in terms of psychological health 
complaints and physical functioning. Improvements in pain and SHCs followed the 
same course in the two groups. At 12 months, there were no differences between the 
groups in terms of health complaints or physical functioning, but the MI group 
reported less use of GPs, better physical fitness, higher perceived coping with health 
complaints and higher satisfaction with treatment, compared to the BI group. 
Both interventions were educational, based on the NIM and thus aimed at reducing 
fear avoidance in general. Both applied clinical guidelines as primary treatment 
principles, although, in the MI group, the treatment plans were individualized 
according to the patient’s preferences, with the intervention more comprehensive and 
focusing on both psychosocial and work factors.  
5.1 Interpretation of main findings 
The three main research questions will be discussed in sections in accordance with 
the overall aims. 
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5.1.1 Return to work 
Three main findings warrant discussion: 1) The increased use of PSL in the MI group 
during the first seven months; 2) the lack of difference in RTW rates between 
treatment groups at 12 and 24 months; 3) the low RTW rates in general.  
Increased use of partial sick leave 
A review of effective RTW interventions for patients sick-listed with chronic MSK 
found that 32% of the identified high-quality treatments resulted in a faster RTW 
compared to control treatments (164). The effective treatment programmes were 
characterized as multifaceted with components including education, information, 
physical exercise, and psychological, social and work interventions. This treatment 
profile was similar to the MI in our study and our results on early PSL are in line with 
these findings. In one study, RTW was faster when physical exercise was combined 
with job-related interventions (112). Physical exercise was an important part of the 
rehabilitation plan in both the BI and the MI, while job evaluations were only part of 
the MI.  
Proactive RTW communication was found to hasten RTW (165). The MI team 
actively recommended RTW in spite of health problems and made an effort to 
explain why. The star plot area in the ISIVET visualized the value of the work, 
supporting proactive RTW communication. Dasinger and colleagues reported similar 
effects, especially in the acute phase of sick leave (166), while, in later phases, work 
environmental factors and lack of supervisor support seemed to override the effect of 
HCPs’ proactivity on RTW. The positive effect of proactive RTW communication 
has also been identified in studies of chronic pain patients (167). In the BI, the 
patients were also encouraged to return to normal activities, including work, as soon 
as possible, but on a general basis and without a closer evaluation of the actual work 
conditions. The communication about potential benefits on health of work 
participation, according to the CATS, may have influenced the patients’ outcome 
expectancies about work participation in a positive way (150). This may also explain 
the increased use of PSL in the MI group. 
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The decision whether to remain on sick leave or return to work is largely influenced 
by the patient’s preferences (90, 168, 169). It is reasonable to assume that the actual 
reduction in sick leave was initiated by the patient or at least in accordance with the 
patient’s preferences. The MI aimed at validating the patient’s perspective of both 
work and life situations in order to find common ground in terms of understanding 
the patient’s situation. The MI also aimed at empowering the patients to become 
active participants in their own care. These strategies are in line with a patient-
centred approach, which are beneficial in terms of the trustworthiness in therapists 
among the patients and outcomes of therapy (170, 171).  
Changes in illness perception could also explain the increased use of PSL. Illness 
perception refers to the subjective experience of health complaints and could be 
influenced by several factors, including knowledge (15). Knowledge influences 
attitudes and beliefs. The biopsychosocial approach and the ISIVET applied in the MI 
could have contributed to an increase in the knowledge and understanding of 
complexity and causal relationships of long-lasting MSK. The understanding of the 
illness could in itself be therapeutic, particularly if the patient suffers from pain and 
fear of serious disease (172). Knowledge and changes in illness perception may also 
change the patient’s outcome expectancies and in turn their health (173). 
The rehabilitation plan was also individualized according to patients’ preferences, 
thus increasing the probability of patient adherence to the plan and positive outcomes 
(171). This may have led to a larger improvement in symptoms in the MI group and 
the patients therefore could have regarded themselves as more able to work.  
A recent Cochrane review on workplace interventions for sick leave concluded that 
workplace interventions reduce the time to RTW in workers with MSK (174). Work 
issues were evaluated in the MI and advice and activities to improve the situation 
were part of the discussions. In a Danish study, a multidisciplinary intervention led to 
a faster RTW compared to the effects of a briefer intervention for a subgroup of 
patients with low job satisfaction (175). Due to the more comprehensive approach in 
the MI, disclosing workplace issues was higher in the MI than in the BI.  
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RTW interventions involving workplaces might actively increase RTW rates, such as 
in the Sherbrook model, although the results have not been reproduced in later 
settings (112, 176, 177). Advice and activities to improve the work situation were 
part of the MI, but it is questionable whether this can be regarded as a workplace 
intervention.  
Some studies indicate that more complex patients benefit more from MDIs (178, 
179). As our patients were mainly chronic pain patients, we should ask whether PSL 
and RTW rates could have been further improved if the MI had been extended. The 
duration of 5.5 hours with the patients is less than on many other MDI treatment 
programmes (180, 181). However, a review of effective RTW programmes for 
chronic MSK concluded that the number of contact hours and total treatment period 
could not explain differences in their effectiveness (164). RTW rates in our BI group 
were lower than in BI groups in other trials, indicating that our population may have 
been more difficult to help (96, 97, 180, 181).  
Low RTW rates  
At 12 months, the status of 45% in both the MI and the BI groups was f-RTW. After 
24 months, the percentages were 43% in the MI group and 37% in the BI group. The 
RTW rates in both groups were lower compared to other trials. Bultmann et al. 
compared the effects of a multidisciplinary work intervention involving TAU for 
patients on sick leave with an MSD for four to 12 weeks and found a 78% (work 
intervention) and a 62% (TAU) RTW rate at the one-year follow-up stage (180). Moll 
et al. compared the effects of an MDI and a BI among patients on sick leave for four 
to 16 weeks with neck or shoulder pain and found a 59% (MDI) and a 58% (BI) 
RTW rate at one year (181). Jensen et al. compared an MDI and a BI for patients 
sick-listed with LBP and reported an RTW rate at one year of 71% (MDI) and 76% 
(BI) (182). Jensen defined RTW as the first four working weeks after inclusion with 
no social transfer payments. A recent Norwegian RCT in specialist healthcare 
compared a work-focused intervention with either an MDI or a BI, in which the RTW 
rates at one year was 70% (work intervention) and 75% (MDI/BI) in patients on sick 
leave with neck and back pain (183). The patients received the intervention in 
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specialist healthcare and RTW was defined as the first five weeks without sickness 
benefits.  
Differences in percentages of RTW rates in these studies compared to our study may 
be related to differences in the definition of RTW or the use of different statistical 
methods. The RTW rates in the aforementioned clinical trials were estimated with 
survival analyses (Kaplan-Meier) and regression analyses (184), where the outcome 
was an accumulated size and not a descriptive status at 12 months, as in our study 
(181-183). Other studies define RTW as cumulative sickness absence hours during 
follow-up (180). This way of reporting work activity gives a more precise picture of 
work disability during follow-up (185).  
Compensation policy variables and labour market may also influence sick leave (77, 
186, 187). The somewhat lower RTW rates in several Norwegian studies, compared 
to studies from other countries, could be due to the Norwegian welfare system where 
patients are granted full sickness compensation the first year of sick leave and about 
two thirds of sickness compensation for several years thereafter. A recent Norwegian 
multicentre study comparing the effects of a BI and BI + either: a) cognitive 
behavioural therapy b) seal oil or c) placebo oil in patients with LBP, reported f-RTW 
rates in groups between 47-56% at 12 months (156).  
The generous Norwegian welfare system could leave us with weak incentives to 
RTW, particularly during the first year of sick leave. Earlier Norwegian trials have 
shown that chronic MSK patients over the years have multiple transitions between 
periods of longer periods of sick leave and partial or full employment, thereby 
avoiding permanent disability (188, 189). National unemployment rates may also 
influence RTW. In Norway, these have been low, between 3% and 4% since about 
1997 (190). However, two former Norwegian RCTs comparing BIs with TAU 
achieved RTW rates of 68% and 70% in their BI groups at 12 months, which is far 
above our 45% (96, 97). However, the difference could be explained by different 
study populations as patients in these two studies were recruited by inviting all 
patients in the area who had been on sick leave for eight weeks for LBP in order to 
 60 
participate in the trial. The patients who were included were randomized to either a 
BI in specialist healthcare or to continue seeing their GP. In our case, the study 
population was recruited from ordinary referrals to specialist healthcare. We found 
that, although 136 different GPs had referred patients to the trial, most of them only 
referred one or two patients. This indicates a highly selected population as MSK is a 
common reason for presenting to primary care where it constitutes up to one third of 
a GP’s workload over the course of a year (4, 191, 192). By inclusion, the patients 
had been on sick leave for an average of 147 days (SD=60), indicating a group 
experiencing mainly chronic MSK. Long periods of sick leave are known predictors 
of poor outcomes concerning RTW (193, 194).  
Equal RTW rates in the BI and the MI group at the one- and two-year follow-
up stage 
RTW rates were similar for the MI and the BI groups at the one- and two-year 
follow-ups. The results are in line with other studies about patients on sick leave with 
MSK where the BI and the MDI performed equally well in terms of RTW (156, 181, 
182). The results are also in line with a Norwegian trial comparing the effects of a 
work-focused MDI with a BI or a conventional MDI in specialist health (183) where 
the patients were on sick leave for an average of 140 days. The results are however in 
contrast with those reported by Bultmann and colleagues who found significant 
improvements in RTW status at the one-year stage of a tailored work rehabilitation 
programme, compared to the effects of conventional care management (180).  
More active workplace involvement as part of an MDI has been found to be more 
effective than control interventions regarding RTW in patients with primarily acute or 
subacute LBP (111, 112). Lambeek et al. included cLBP patients and concluded that 
an MDI was more effective than TAU (114). In a Cochrane review on workplace 
interventions for preventing work disability, the authors suggested that they were 
effective in reducing sickness absence among workers with MSK (195). A workplace 
intervention was defined by “changes to the workplace or equipment, changes in 
work design and organisation, changes in working conditions or work environment 
and occupational management with active stakeholder involvement of (at least) the 
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worker and the employer”. The review was updated in 2015, with the authors then 
concluding that a workplace intervention reduced time to the first RTW in workers on 
sick leave with MSK, compared to the effect of usual care, but that RTW rates in the 
long term are not affected (174). The MI in our study had a particular but also limited 
focus on the work situation and was probably not classifiable as a multidisciplinary 
work intervention, although the work situation was evaluated and discussed, with 
initiatives directed at the work situation frequently part of the rehabilitation plan.   
Other trials have revealed subgroups benefiting from either a BI or an MDI in terms 
of RTW. Women have been found to benefit more from an MDI compared with a BI 
and/or TAU in patients with chronic widespread pain (CWP) (178). Another trial on 
cLBP and RTW found BIs to be more beneficial than MDIs for men (196). In our 
paper on predictors, gender did not predict s-RTW, either at three or 12 months (197). 
Jensen et al. found in the course of subgroup analyses that MDIs were beneficial to a 
vulnerable group of patients at risk of losing their job (182). 
It seems difficult to identify efficient RTW interventions in studies of patients with 
chronic MSK mainly due to the heterogeneity of the patient group. A recent Cochrane 
review concluded that MDIs were more efficient than physical treatment but not TAU 
for RTW in patients with cLBP (108). Management of chronic MSK may require 
alternative approaches and subgroup knowledge to tailor interventions according to a 
risk profile. In our study, about 10% were diagnosed with fibromyalgia, 12% were 
diagnosed with neck pain and 7.8% with shoulder pain. This could explain the 
relatively low RTW results. The Cochrane review also stated that there is little 
scientific evidence for the effect of MDIs on CWP and fibromyalgia (23). Patients 
with chronic upper-extremity MSK have a higher degree of sick leave than LBP 
sufferers (198, 199).  
5.1.2 Predictors of sustainable return to work 
s-RTW on an individual level is defined as increased work participation in three 
consecutive months, compared to baseline. The process of RTW is complex and may 
involve multiple transitions between working, being partly or being fully out of work 
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after work rehabilitation (188, 189). It would be valuable to discover whether 
increased work participation is limited to four weeks or is more sustainable. Analyses 
revealed that MI was the strongest predictor for s-RTW at three months.  
Earlier studies on predictors for outcomes of MSK focused more on predictors for 
prolonged sick leave or disability, rather than on factors predicting RTW (73, 200). 
Jensen and co-workers found seven factors to predict unsuccessful RTW in patients 
with LBP within one year, among them, pain score, bodily distress, low expectation 
of RTW, and blaming work for the pain (200). A review of predictors of sickness 
absence in patients with cLBP concluded that, due to the heterogeneity of studies, no 
core set of predictors could be established (73). Dekkers-Sanchez and co-workers 
explored promoting factors for sustained RTW through interviews with vocational 
rehabilitation professionals and concluded by recommending combined, tailor-made 
interventions in a holistic approach involving the employee and their environment in 
order to address the multicausality of work disability and maximize RTW outcomes 
(201). This latter recommendation complements elements of the MI in our study and 
could help to explain the finding that the MI predicted s-RTW at three months. 
Another explanation could be that the MI changed patients’ expectancies about RTW 
(150). In a recent publication on predictors of RTW in patients with long-lasting 
LBP, high expectancies of RTW was a strong predictor for RTW (202). The 
comprehensive evaluation of work factors, combined with the communication of the 
value of work, could have influenced the response outcome expectancy concerning 
work participation as described in the CATS (150). If work actually turned out to be a 
beneficial next step, positive feedback could have dampened the stress response and 
facilitated a continuation of work participation.  
In the present study, a subgroup of patients who experienced low support at work 
benefited more from the MI than the BI in terms of RTW. The OR had a wide 
confidence interval so the finding should be interpreted with caution. A review of 
work-related risk factors for LBP reported strong evidence for low social support in 
the workplace being a risk factor for back pain (203). Dissatisfaction with support at 
work should be visualized in the ISIVET and discussed with the patient. The 
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identification of this subgroup and the handling of this finding in the ISIVET could 
explain why the MI was beneficial for RTW in this subgroup. Our finding could be 
related to another study on RTW for patients with MSK, which found that a subgroup 
of patients who were vulnerable to the loss of work benefited more from an MDI than 
a BI (204).  
Multiple pain sites, higher levels of pain and widespread pain are found to predict 
poor work outcomes after sick leave (205, 206). Levels of pain did not predict 
outcome in our population, but the belief that work was the cause of the pain was a 
predictor for s-RTW at three months. This belief could be related to fear avoidance 
beliefs for work (FABW), which are found to be more prevalent in chronic pain than 
acute pain and to be a risk factor for non-RTW (200, 207-209). A reduction in FAB is 
found to predict RTW (210). Our finding could be related to such a change in FABW, 
possibly through the educative approach based on NIM in both interventions (96, 
100).  
The length of sick leave by baseline was a risk factor for non-RTW at 12 months, and 
is thus a well-known predictor (36, 37, 211, 212).  
We identified only three predictors of s-RTW in our study. This is in line with a 
review evaluating risk and prognostic factors of MSK classified into ICF dimensions 
(213). The authors found strong evidence of poor job satisfaction as a risk factor for 
LBP, and having fear avoidance beliefs and meagre support at work as a risk factor 
for persistence of LBP; but, first and foremost, they found high evidence that a 
number of factors was not prognostic. Laisne et al. recently reviewed biopsychosocial 
predictors of prognosis for patients with MSK (69). They concluded that it remains 
difficult to identify a clear set of prognostic factors in MSK, although outcomes seem 
to be determined more by psychosocial factors than biomedical factors. The authors 
recommend a biopsychosocial approach from the onset of health complaints and call 
for more homogenous models and measurement methods.  
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5.1.3 Effects on health and coping 
The results of this trial followed the same pattern in terms of primary and secondary 
outcomes. At three months, there was a larger improvement in health complaints, 
physical functioning, somatization, anxiety and depression in the MI group compared 
to the BI group, but the effect sizes were small to medium. By 12 months, there were 
no differences between the treatments groups concerning these parameters. However, 
the MI group reported lower use of GPs, better physical fitness, higher perceived 
coping with health complaints and higher satisfaction with treatment compared to the 
BI group.  
Health effects 
The faster improvements in health in the MI group could be secondary to increased 
work participation, as work is a determinant of good health (30). However, the 
reverse causality, that health improvements causes increased work participation, 
cannot be excluded based on these data. Studies attempting to address the effects of 
PSL versus FSL on health show inconsistent results (116, 214, 215). Sieurin and co-
workers found that patients on PSL believed that part-time work was good for their 
health (216). In 2013, Shiri and co-workers assessed the health effects of early PLS in 
an RCT comparing PSL with FSL, and concluded that PSL improved self-related 
general health and health-related quality of life in the early stage of work disability 
(217). Additionally, PSL did not aggravate pain-related symptoms or functional 
ability.  
Another possible explanation for our findings is that a comprehensive approach is 
found to be more beneficial for clinical outcomes than a less comprehensive approach 
for chronic pain patients (107, 108, 218). Reme et al. found no differences in RTW 
between groups at one year, but the most comprehensive intervention was superior to 
the BI on general health and patient satisfaction with treatment for patients on sick 
leave with MSK (156). However, Moll et al. found that an MDI performed equally 
well with a BI on health outcomes in patients on sick leave with MSK (181).   
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MSK improvements were similar in the BI and the MI in our study both at three- and 
12-month follow-ups. This is in line with other studies on RTW interventions for 
MSK, where effect sizes on health outcomes are equal after brief versus more 
comprehensive interventions at the one-year follow-up (156, 182, 210). The work 
disability paradigm claims that cLBP or MSK is not only a clinical pain problem, but 
also a problem involving work and psychosocial factors (82). RTW programmes for 
chronic MSK should therefore focus more on regaining normal activity in spite of 
pain problems than on reducing symptoms (20, 30, 82, 219). One might question if 
the differences in time course for some clinical outcomes in our study are clinically 
relevant as effect sizes are mainly small. However, considering that chronic pain is a 
complex condition with a high degree of co-morbidity and somatization, even small 
changes could be of clinical relevance.  
Coping 
Maladaptive pain coping behaviour was identified as a strong predictor of persistent 
disabling LBP in a systematic review (220). The patients in the MI group reported 
higher perceived coping with health problems at the one-year follow-up when they 
were asked to evaluate their coping abilities. They also reported less use of GPs at 
both three- and 12-month follow-ups, which could also be a sign of improved coping.  
A sense of coping could be due to positive outcome expectancy (150). It may also 
relate to actual coping experiences and perceived self-efficacy. Bandura and his co-
workers found that people’s behaviour is strongly influenced by their confidence in 
the ability to perform certain tasks (221). Given that the patients in our trial 
constituted a selection of mainly chronic pain patients referred from primary care, we 
could assume that attempts were made to rehabilitate them in different ways in 
primary care without success. This could leave us with a sample with a history of 
experiences of helplessness and hopelessness related to health problems and work 
participation (150). As the rehabilitation plan was tailor-made and agreed in 
cooperation with the patient, it could have strengthened both the outcome expectancy 
and the confidence in ability at the follow-up stage (222). Interventions practising 
SDM have been found to be more beneficial in terms of health outcomes and coping 
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in the case of fibromyalgia patients (223). Furthermore, patients who are engaged in 
decision-making are generally more motivated towards making lifestyle changes and 
thus their outcomes are better (224). When the patient adhered to the rehabilitation 
plan, it may have provided the patient with a strengthened sense of self-efficacy and 
positive coping expectancies. Improved expectancies about coping may also 
influence lifestyle choices in a positive direction (225). 
If the intervention succeeds in explaining and reassuring the patient about their 
medical state, fear avoidance behaviours may be reduced. This could further promote 
change in behaviour and the sense of coping, as fear avoidance beliefs are common 
obstacles to rehabilitation in pain patients (209).  
However, effective communication is a prerequisite for a number of these effects to 
occur. Communication in therapy influences outcome and coping (226, 227). 
Communication in therapy strongly influences therapeutic relations, which again 
influence outcomes (228). In a study on chronic pain patients and how the patient-
physician relationship could promote the resilience process, three main themes were 
identified: the doctor providing psychological support, the doctor promoting patients’ 
health literacy related to chronic pain and its treatment, and empowering patients to 
find the right treatment (229). These findings correspond more with elements in the 
MI than the BI. The MI with the ISIVET represents a patient-centred approach in the 
frame of the biopsychosocial understanding of illness, while the BI primarily focuses 
on the individual. The ISIVET sought to individualize treatment due to patient 
preferences and facilitate education about the problem area. The patients were offered 
an opportunity to participate in their care in ways that enhance partnership and 
understanding. The MI group also reported high satisfaction with treatment. This 
could indicate that more comprehensive interventions are more in line with the needs 
and expectations of patients with chronic MSK.  
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5.2 Strengths and limitations   
The RCT design is a major strength of this study. The randomization was concealed, 
computer-generated and based on age and gender. This guaranteed equally sized 
groups. A research assistant, who was not involved in the treatment, was informed 
about treatment allocation for each patient. The blinding of treatment is 
recommended to prevent bias, blinding either the patients or the therapists in this 
study was not possible. The low loss to follow-up on treatment in both groups, 
indicate the interventions are feasible in a clinical setting. All included patients were 
analysed on work outcomes as intention-to-treat, regardless of drop-out of treatment. 
Among other strengths of this study are the large sample sizes, the long follow-up 
time for work outcomes, and the use of register data for work outcomes and validated 
questionnaires on secondary outcomes. Register data gave access to complete 
information on sickness benefits for every participant at every month of follow-up. 
These types of longitudinal data on work outcomes could be particularly useful when 
studying a population with MSK, as they give access to fluctuations in sick leave 
over time (230) as workers with chronic MSK are at risk of recurrent sick leave 
(231).  
The patients in the trial were selected from ordinary referrals to the outpatient clinic 
and rather broad inclusion criteria were applied (referred due to MSK and sick-listed 
for one to 12 months). No extra effort was made to recruit patients. This suggests that 
the study population resembles patients in a specialist healthcare outpatient clinic. 
However, only 284 (53%) of the 534 patients who were expected to be eligible due to 
inclusion/exclusion criteria were included and randomized. Of these, 107 were 
excluded due to not meeting criteria, while 100 refused to participate. Another 43 
could not be reached by telephone, which may also have been a sign of declining. 
The relatively large number of patients declining to participate could limit the 
external validity of the study as the recruited population typically differs from the 
population not recruited in terms of age, sex, severity of disease, education and social 
class (232). It might have been interesting to know the reason why patients declined 
to participate, but we have no data to analyse for this issue. However, the number of 
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eligible patients not invited to participate or who decline to participate in RCTs is 
estimated to be between 20% and 80% (232). Our analyses revealed that the study 
population (n=284) was referred by 136 different GPs, with most GPs only referring 
one or two patients; only a few referred more than four patients. This indicates the 
population was highly selected as we know that those with MSK are among the most 
prevalent patients in GPs’ practices (4, 10). The referred patients are presumably 
those who are difficult to help or to diagnose in primary care.  
External validity could have been improved if we had performed a multicentre study 
instead of a single-centre study (233).  
We cannot exclude a Hawthorne effect (a placebo/nocebo effect) on both the MI and 
the BI. Such effects can hamper external validity. However, both treatments were 
performed in specialist healthcare and both were comprehensive, compared to most 
other regular treatments in healthcare in Norway. We may therefore assume that 
nocebo effects were minimized. Besides, the patients were unaware of any details 
about the intervention to which they were not allocated.  
The treatment teams were separated, reducing the risk of mixing between the two 
interventions. Audio- or videotaping was not performed, limiting the possibility to 
evaluate the treatment teams’ adherence to the manual. The ISIVET was a new tool, 
and the MI teams practised regular meetings to ensure equal practice of the method. 
The BI method was well known to the therapists on the BI teams. One limitation was 
the participation of less experienced and a greater number of therapists on the MI 
teams compared to the BI teams. The first author (RB) had developed the first draft of 
the ISIVET, but the final version of the tool was developed at the DPMR during the 
planning of the study. RB participated in the study and treated 29 patients as part of 
an MI team. However, outcomes were not based on ISIVET evaluation scores, but on 
scores from the questionnaires and national register data, thus reducing the possibility 
of bias.  
Loss to follow-up on questionnaires can also produce attrition bias, which may 
influence both internal and external validity (234). The return rate of the 
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questionnaires declined to 79% (MI) and 66% (BI) at three months, and 60% (MI) 
and 61% (BI) at 12 months, reducing the validity of data in secondary outcomes in 
Paper III. This did not affect the predictor analyses in Paper II as we used baseline 
data where the response rate was close to 100% in both groups. There were no 
significant differences in baseline scores between non-returners and returners of 
questionnaires at 12 months except from the HSCL depression score, which was 
significantly lower among the non-returners (mean=1.47, SD=0.46) compared to the 
returners (mean=1.60, SD=0.55). This might indicate that the non-returners had fewer 
mental health complaints compared to the returners, which could have influenced the 
outcomes in Paper III.   
A very homogenous study population could be good for the internal validity, but 
often hamper the external validity of a study. Clinical trials are often explained as 
either explanatory or pragmatic (235). Based on the setting of this trial, the broad 
inclusion criteria, the heterogeneous patient population and the individualized 
rehabilitation plan, we consider this trial to be a pragmatic trial. Pragmatic trials are 
designed to provide estimates of treatment effects that are generalizable to clinical 
practice (235). Participants may have been receiving other healthcare during the study 
and patients in the treatment groups may not have received the exact same treatment 
as treatment were tailored to their needs. The 51 different diagnoses of the present 
trial population indicate a heterogeneous population, which could have increased 
external validity. It may also indicate a population with a high degree of co-
morbidity, increasing the possibility that other health problems than MSK were a 
barrier to work participation. Co-morbidity in patients with MSK could decrease 
RTW rates (236). The exclusion of individuals with poor Norwegian skills hampers 
the external validity. We might expect results in our trial to be transferable to patients 
with chronic MSK who are on long-time sick leave and have been referred to 
specialist healthcare. Transferability might be limited by context, such as the welfare 
system, as the generous Norwegian welfare model with its sickness benefits and 
regulations, as well as dismissal protection, could act as a nocebo in relation to RTW, 
at least for the first year of sick leave. Studies from other countries with a less 
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generous welfare system or dismissal regulations report higher RTW rates (111, 180, 
204, 237). 
At the time of planning our study, reviews recommended MDIs for the management 
of complex, chronic non-malignant pain (107); but, for RTW outcomes, 
recommendations of MDIs were inconsistent, although both MDIs and BIs were 
reported to be superior to TAU (23, 109, 164, 238). Brox et al. recommended, in a 
review, delivering brief education interventions to cLBP patients to increase RTW; 
however, the control group received TAU rather than another active treatment in 
specialist health (98, 239).  
We could question whether the two interventions in our trial were too similar to 
expect a main difference in outcome. However, the MI put considerably more weight 
on patient education and involvement in the process of working out a rehabilitation 
plan. This might have influenced the patients’ outcome expectancies and be a major 
explanation of the differences in outcomes between treatment groups, albeit on a 
small scale.  
5.2.1 Statistical considerations 
This trial applied validated questionnaires, which were sent to the study participants 
by post to be filled out at home. The questionnaires assessed sociodemographic, 
work- and health-related factors. The data on work participation were provided by 
register data. This assessment allowed us to analyse the interaction between work, 
health and demographic factors. Although a few more individuals dropped out of 
treatment in the BI by the two-week follow-up stage (15 versus 4 in MI), the risk of 
attrition bias was low. 
The main outcome was RTW by three and 12 months, although we had data for 24 
months. We differentiated RTW into f-RTW and p-RTW and OOW on a monthly 
basis for each individual. Another Norwegian multicentre study also differentiated 
between f-RTW and p-RTW on a monthly basis and defined increase in work 
participation, compared to baseline, as a success criterion for RTW (156). It did not 
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call for three consecutive months with increased work participation. Other studies 
have defined RTW as retrieving no compensation from the NAV for a four-week 
period (111, 114, 182) or for a five-week period (183). A review of RTW definitions 
concluded that different definitions are highly correlated and give similar results in 
terms of prediction (240). The multinomial logistic analysis explored the RR ratios 
for p-RTW and f-RTW between groups every month for the 24 months of follow-up. 
Multiple analyses increased the risk of finding significant differences by chance. The 
month-by-month status concerning work participation was reported on a group level. 
We do not know whether individuals RTW at one month continued to stay at work in 
the subsequent months. Therefore, we defined s-RTW as increased work participation 
for three consecutive months compared to baseline, with the first month as the s-
RTW month. Analyses revealed that, by the 12-month follow-up stage, 63.8% of the 
MI group and 58.7% of the BI group had achieved s-RTW at some point.  
In the prognostic model in Paper II, the included variables were dichotomized, 
meaning that we could perform logistic regression. Dichotomization offers the 
possibility to include both nominal and ordinal data as independent variables in the 
regression model; conversely, this leads to a loss of information in the analyses, a loss 
of statistical power and a decreased probability of detecting an effect that is present, 
that is, a Type II error (241). The fact that we also dichotomized the outcome variable 
(s-RTW) fully amplifies this effect with a systematic loss of measurement 
information. When selecting study factors for the model, one should select formerly 
known predictors (242) and all potential prognostic factors should be included to 
avoid omitted variable bias, which may induce underfitting of the results and 
successively poor transportability to other populations (242, 243). For patients on 
long-term sick leave with MSK, there is no consensus about all of the possible 
predictive factors, so the selection of factors included in this trial was partly informed 
by clinical experience and partly by existing empirical data on prognosis for RTW 
after sick leave. The risk of including too many variables in the model is present, with 
an overfitting of results as a possible outcome (244). Neither do we know if all the 
important predictive variables were included. We did not adjust for education, which 
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we intended to, as we found that the answers on education in the questionnaires left 
us with the category labelled as “other” difficult to define.  
The power calculations were performed for the main outcome, RTW, and should 
have been adequate for the calculations in Papers I and III. However, the number of 
patients was too small for subgroup analyses. Analyses of differences in outcome 
between different diagnostic groups or gender might have been relevant to perform. 





This thesis summarizes the results from an RCT by comparing the outcomes of two 
interventions in specialist healthcare. The trial is pioneering work on the novel 
ISIVET tool, which is part of the MI. 
The results show that MI and BI performed equally well in terms of RTW after one 
and two years in a population sick-listed with chronic MSK and referred to specialist 
healthcare. The less resource-demanding BI is therefore sufficient for RTW outcomes 
in the long run for this patient group. The MI did however speed up the RTW process 
through the increased use of PSL in the first months of follow-up, which could be 
valuable as an earlier RTW may reduce the risk of recurrent sick leave.  
Patients who believe that work causes the pain, benefit from both interventions for 
RTW, and BI might be sufficient for this effect. Otherwise, we cannot conclude that 
either MI or BI is beneficial for any particular subgroup, although there is the 
possibility that patients experiencing low support at work benefited particularly from 
the MI for work outcomes.  
The MI group reported faster improvements in mental complaints and physical 
functioning, equal improvements in pain, and stronger improvements in coping and 
physical fitness compared to the effects of the BI at 12 months. Together with the 
high satisfaction with treatment in the MI group, we can assume that there are 
elements in the MI that were more beneficial, compared to the BI, for this patient 
group. We suggest that these beneficial effects are related to improved 
communication in therapy, strengthening patient education and involvement in 
treatment decisions, with a subsequent positive influence on outcome expectancies. 
However, results so far do not advocate the use of a more resource-demanding 
intervention for all patients.  
A large number of interventions exists to facilitate and hasten RTW after sickness 
absence due to MSK. The key question, “What works and for whom?”, has not yet 
been answered, primarily due to the heterogeneity of studies. Finally, we must 
 74 
consider the Norwegian welfare system to be a possible barrier to RTW, limiting the 
effects of any RTW intervention in a Norwegian setting.  
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7. Future research 
In spite of the vast body of research on RTW interventions for patients with chronic 
MSK, we found no consensus on how to treat these patients or who might benefit 
more from what kind of approach. This trial included elements of established 
significance: a multidisciplinary biopsychosocial approach, patient education and a 
focus on work and on communication in therapy. A major impact of these elements 
on outcomes is however missing as the BI almost performs as well as the MI in the 
long run. There are possibly too many similarities between the methods to expect a 
significant difference. The overall RTW rates were low, indicating a study population 
that is difficult to rehabilitate for work. At this time, out of the two interventions, we 
can say that the BI seems sufficient for this group to reach their potential for 
improvement.  
However, the MI demonstrated consistent results, but with small effect sizes, while 
the assessment revealed no obviously adverse effects and the patients reported high 
levels of satisfaction with treatment. As the field of knowledge involves a continuous 
search for active elements in the RTW process, we could consider further exploring 
the importance of communication in therapy for this patient group. In a future clinical 
trial, we suggest including a population on sick leave for up to six and not 12 months, 
as the length of sick leave predicts non-RTW. We could also combine the BI and the 
ISIVET and involve workplace stakeholders more actively as this was insufficient in 
this trial. The possibility of involving the GP in follow-up consultations, for example, 
at three and six months should also be considered. That would ensure a longer 
follow-up time for the rehabilitation plan and at a lower cost than in specialist 
healthcare. The involvement of the GP, who is the gatekeeper of the sickness 
certificate, could be beneficial for RTW outcomes. The GP also has direct 
communication with the NAV.  
A control group could be allocated to a BI in specialist healthcare, while cost-benefit 
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Abstract Objective: This randomized clinical trial was
performed to compare the effect of a new multidisciplinary
intervention (MI) programme to a brief intervention (BI)
programme on return to work (RTW), fully and partly, at a
12-month and 24-month follow-up in patients on long-term
sick leave due to musculoskeletal pain. Methods: Patients
(n = 284, mean age 41.3 years, 53.9 % women) who were
sick-listed with musculoskeletal pain and referred to a
specialist clinic in physical rehabilitation were randomized
to MI (n = 141) or BI (n = 143). The MI included the use
of a visual educational tool, which facilitated patient-
therapist communication and self-management. The MI
also applied one more profession, more therapist time and a
comprehensive focus on the psychosocial factors, particu-
larly the working conditions, compared to a BI. The main
features of the latter are a thorough medical, educational
examination, a brief cognitive assessment based on the
non-injury model, and a recommendation to return to
normal activity as soon as possible. Results: The number of
patients with full-time RTW developed similarly in the two
groups. The patients receiving MI had a higher probability
to partly RTW during the first 7 months of the follow-up
compared to the BI-group. Conclusions: There were no
differences between the groups on full-time RTW during
the 24 months. However, the results indicate that MI has-
tens the return to work process in long-term sick leave
through the increased use of partial sick leave.
Trial Registration: http://www.clinicaltrials.gov with
the registration number NCT01346423.
Keywords Return to work  Sick leave  Chronic pain 
Work disability  Coping
Introduction
Musculoskeletal disorders are amongst the primary causes
of work disability in Western societies and thereby repre-
sent enormous costs to the community in economic terms
[1]. Painful disorders of the back, neck and upper limbs are
the most frequently used diagnoses, with sickness absence,
long-term incapacity for work and permanent disability as
frequent consequences [2]. In Norway nearly half of all
sickness absence is due to a musculoskeletal pain diagnosis
with low back pain (LBP) as the largest single cause [3].
Health measures in Western societies are improving, but
sickness benefits and disability claims due to muscu-
loskeletal disorders increase [4]. Maintaining activity
including work, in spite of muscular pain, is an important
part of the recovery process as the opposite delays recovery
[5–7]. The process of return to work (RTW) is therefore
clearly a major concern in this patient group [8, 9].
The journey from acute muscle pain to long-term sick-
ness, work absenteeism and disability has been widely
investigated. Such studies have revealed that psychological
and social factors, as well as somatic pathology, influence
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chronicity and disability [10]. When the duration of sick-
ness-absence due to musculoskeletal pain exceeds 8 weeks,
the prognosis worsens and the probability of RTW is
reduced [8, 9, 11].
The process of RTW in chronic pain can be conceptu-
alized as a complex human behaviour change, where the
patient her/himself takes the final decision on RTW or not.
However, the general practitioner (GP) is the main gate-
keeper of access to sickness benefits [12]. The patient’s
own evaluation of their RTW is influenced by several
personal, social, economic and work-related factors [13–
15]. According to behaviour models, a change in behaviour
is influenced by knowledge, attitudes, norms and self-ef-
ficacy [15, 16]. Banduras [17] Social Cognitive Theory
posits a multifaceted causal structure to explain how
human motivation, behaviour and well-being are regulated.
In this model, self-efficacy beliefs, goals, outcome expec-
tations and perceived environmental impediments and
facilitators, all operate together as regulators of motivation
and behaviour. This corresponds to the suggestion that
interventions in sick-listed, chronic pain patients should not
primarily focus on pathology but rather, on adapting to a
complex situation which should include giving more
attention to coping, self-management skills, environmental
factors, workplace support and patient education [18]. This
may enhance the patient’s positive response outcome
expectancies (coping). According to the Cognitive Acti-
vation Theory of Stress (CATS), such improvements will
dampen the stress response, which, in the next step, might
help patients towards a more constructive handling of
complaints [19].
In general, the multidisciplinary approach (MDA) is
accepted as a reasonable approach to treat chronic pain
patients, as this should be regarded as multicausal [20–22].
In a recent Cochrane review, MDA was found to be
favourable in decreasing pain and disability compared to
usual care [23]. However, the effects on the RTW of
multidisciplinary interventions for chronic muscular pain
have been conflicting [7, 23, 24].
The majority of chronic musculoskeletal pain conditions
including LBP, are characterized by the lack of objective,
pathological findings although the patients present numer-
ous additional subjective health complaints and experience
reduced work ability [25]. The GP’s assessment concerning
sick leave must, to a great extent, rely on the patient’s
description of his/her condition in combination with the GP
making an effort to understand the workplace environment
and the actual work demands. Several studies have
revealed a need to expand clinicians practice in this field,
as many GP’s do not readily engage in workplace discus-
sions with the patient [26, 27]. There is growing evidence
that occupational factors influence disability and that GP’s
proactive communication related to health and workplace
strategies is of major importance to RTW [28]. This calls
for approaches where clinicians more actively assess
occupational factors and health complaints together in the
rehabilitation process.
In this study, we applied a multidisciplinary interven-
tion (MI) that is tailored to highlight the complexity of
long-term pain problems. The MI included an assessment
of work, family situation, lifestyle, coping strategies and
health problems. The MI applied a novel educational tool,
the Interdisciplinary Structured Interview and a Visual
Educational Tool (ISIVET), to establish an overall picture
of the patient’s situation through visualization. The
underlying hypothesis was that this design could intro-
duce a new cognitive approach to cope with health
problems. This might strengthen the motivation of
patients to go through with changes, thereby improving
the actual coping and resuming work. The active control
group received a brief intervention programme (BI),
based on a non-injury model which has proved particu-
larly effective on RTW in patients with sub-acute LBP
[29–32]. The non-injury model is based on the under-
standing of the back or the body as a robust structure
where pain should not necessarily be taken as a sign of
injury caused by inappropriate behavior or any wrong-
doing. This view is communicated to reduce pain-initiated
fear and secondly to encourage natural movements and
reduce tense and awkward movements which often come
from the belief that pain is caused by an injury of the
body and that care, protection and restrictions are
mandatory which comply with the injury-model.
Objectives
The objective of the study was to test if a MI is more
effective than a BI on RTW in patients sick-listed due to
musculoskeletal pain. We hypothesized that the MI would
be superior to BI in increasing RTW over a period of a
24-month follow-up.
Materials and Methods
Study Design, Recruitment and Participants
This study was a randomized clinical trial which took place
at two different outpatient clinics at the Department of
Physical Medicine and Rehabilitation (DPMR), Innlandet
Hospital Trust, Norway, from 2011 to 2013. All of the
patients from two different counties in the south–eastern
part of Norway, sick-listed for musculoskeletal pain and
referred to the DPMR, were considered for participation.
The study followed the CONSORT statement for reporting
of randomized trials.
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The inclusion criteria were: aged between 20 and
60 years, a sick leave degree between 50 and 100 % due to
musculoskeletal pain and for\12 months, and at least 50 %
employment contract. The exclusion criteria were: preg-
nancy, current cancer, osteoporosis, recent physical trauma/
injury, serious mental illness, rheumatic inflammatory dis-
eases, not capable of understanding and speaking Norwegian,
or being involved in an on-going health insurance claim.
A total of 534 patients were screened for eligibility,
whereby 250 were found to not be eligible for different
reasons (Fig. 1). This study included 284 patients referred
from 136 different GPs. These patients were randomized to
either MI (n = 141) or BI (n = 143). The two interven-
tions were performed by different teams and no clinician
working in the MI-team ever worked in the BI-team. The
time from inclusion/randomization to baseline assessment
at the clinics was between one and 2 weeks.
Context
All lawful residents of Norway are included in the Nor-
wegian public insurance system. This provides health ser-
vice benefits and pensions for all members of the National
Insurance Scheme, administered by the Norwegian Welfare
and Labour Administration (NAV). When a worker, due to
a medically acknowledged disease, is sick-listed by his/her
GP, the workers’ compensation programme, which is
administered by NAV, provides 100 % coverage for lost
income from day one until the person can work again, up to
52 weeks. The employer covers the first 16 days. After
1 year, the NAV covers the long-term rehabilitation ben-
efits or disability pension, providing approximately 66 %
of the patient’s former income. These benefits can also be
combined with work if the disability constitutes a mini-
mum of 50 %.
Received treatment session at 
3 months follow-up (n=134)
Treatment drop-out (n=7)
Received treatment session
at 2 weeks follow-up (n=128)
Treatment drop-out (n=15)
Received baseline treatment 
session (n=143)
Received baseline treatment 
session (n=141)
Received treatment session at 
2 weeks follow-up (n=137)
Treatment drop-out (n=4)
Excluded (n=250):
Not meeng inclusion criteria (n=107)
Declined to parcipate (n=100)
Other reason: Not responding at 
request on study parcipaon (n=43)
Randomized (n=284)
Allocated to MI (n=141) Allocated to BI (n=143)
Assessed for eligibility (n=534)
Analyses on RTW for 24 
months follow-up (n=143)










intervention, RTW return to
work
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Interventions
The Multidisciplinary Intervention with the ISIVET
Baseline Assessment Initially, the patient met each of the
three members of the multidisciplinary team successively
(social worker, physician and physiotherapist). The social
worker first interviewed the patient about their family life,
social life, education and economics and then collaborated
with the patient on scoring the ISIVET-figure ‘‘Working
conditions’’ (Fig. 2). This evaluated seven different issues:
work-related stress, satisfaction with job-tasks, workload,
collegial relationships, leadership, degree of challenges at
work and occupational participation.
The physician first interviewed the patient about the
family’s health, as well as his/her former and present
health. Then the physician conducted a physical examina-
tion, concluding with an ICD-10 diagnosis. Finally the
physician and the patient collaborated on scoring the ISI-
VET-figure ‘‘Quality of life’’. This evaluates the following
issues: physical complaints, psychological wellbeing,
sleep, energy, physical activity, social participation and
occupational participation.
The physiotherapist assessed the musculoskeletal prob-
lems of the patient and conducted a physical examination.
The ISIVET comprised a manual and the two figures,
which were star-plots with seven axis representing seven
different issues. The scores on each axis were set between 1
and 10, with ‘‘10’’ positioned in the periphery of the star-
plot, indicating an optimally positive situation. Meanwhile,
‘‘1’’ was located in the centre of the star-plot, indicating a
maximum negative situation. The manual gave illustrating
examples of situations at different scoring levels and,
through discussion, the patient and the clinician identified
the right score for every issue. When all of the scores were
completed, a line was drawn between the scoring points,
which produced an area in each figure. The area was
coloured for better visualization for the patient, as well as
for the clinicians. The problem areas were demonstrated by
a lack of colour, while existing resources stood out as the
coloured area.
When the sessions with the three clinicians were
completed, the whole team met briefly to share their
findings and general impression of the patient and her/his
situation. The possible barriers to work-participation,
maintaining factors to the pain problem and eventually
other important issues, were highlighted. Following this,
the patient joined the team for an evaluation on the total
situation including health problems and work. The two
figures with their coloured areas were central in this phase
and when discussing problem solving and possible fields
of actions. The patient played a major role in deciding the
ways to go forward, with guiding from the areas and with
the team as a counselling partner. The agreement on the
actions was written down in a list, which constituted the
patient’s rehabilitation plan. The actions were typically
related to the handling of pain and fear avoidance, to
lifestyle, particularly physical activity, and to family or
work matters. When leaving the clinic, the patient
received a paper-copy of the ISIVET-figures with the
coloured areas and the rehabilitation plan listed as the
points to be followed. The complete baseline assessment
lasted 3.5 h.
Two-Week Follow-Up The patient met the physiothera-
pist for 1 h to evaluate the rehabilitation plan and work
through the ISIVET once more. New areas were coloured
with a second colour (Fig. 2). The visualization of the
delta-areas was a matter of attention and reflection. Pre-
vious advice and actions were highlighted according to
this, and adjustments to the rehabilitation plan were
eventually made.
Three-Month Follow-Up The patient and the whole team
met for 1 h to sum up the situation and evaluate the
interventions so far. The ISIVET was worked through and
new areas were coloured with a third colour. Eventually,
they adjusted the rehabilitation plan.
During the study period, four different physicians, all
specializing in physical medicine and rehabilitation, two
different social workers, and four different physiotherapists
were engaged in the MI-treatment. The total face-to-face-
time spent with the patient during the MI was 5.5 h.
The Brief Intervention (BI)
BI as applied in this study, is based on the studies by Indahl
[30, 31] and Hagen [29], and we used the modified version
of BI which is described in Hagens work.
The BI comprised two sessions: a baseline session













Fig. 2 The ISIVET-figure ‘‘Working conditions’’, assessed three
times
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physician and a physiotherapist, and a two-week follow-up
with the physiotherapist for about 1 h.
The BI is based on a non-injury-model for LBP. It aims
to reduce fear and concern and help the patient to stay
active despite the pain, unless ‘‘red flags’’ [33] are identi-
fied, emphasizing the fact that the back is a strong and
robust structure and that return to normal activity would be
beneficial. The essential feature of the method is giving the
patient time to express problems, worries and thoughts.
This is followed by a thorough medical, educational
examination, where any somatic findings are explained to
the patient. The patient is informed about the good prog-
nosis and importance of staying active.
Therapist treatment manuals were based on the current
guidelines [7] and the manual used by Hagen [29]. A
physician, who was a specialist in physical medicine and
rehabilitation, and a physiotherapist, carried out the BI.
Both of the therapists were experienced in the method. The
total face-to-face-time spent with the patient during the BI
was 3.5 h.
Data and Outcome
The social insurance register provides information about
the start and stop dates for payments of sickness benefit,
rehabilitation benefits, disability pension and unemploy-
ment benefits. For payments of sickness benefits and dis-
ability pension, we have information about the degree of
disability and hence, indirectly, the degree of work par-
ticipation. Only the payments for absences exceeding
16 days are refunded by the National Insurance. Therefore,
absences that last 16 days or less are not included in our
data.
We used the register data to define the work/social
insurance status in each calendar month after inclusion in
the trial. The register data provided follow-up data on
every participant in both treatment groups for the 24-month
follow-up.
Due to the inclusion criteria, all of the participants were
employed and on sickness benefits at baseline. We defined
that, if more than 50 % of the working days in a given
calendar month were spent on full-time sick leave, the
status for that month was given as ‘‘out of work’’ (OOW).
If more than 50 % of the working days in a given calendar
month were spent on partly sick leave, the status for that
month was given as ‘‘partly return to work’’ (p-RTW). If no
benefits were provided in more than 50 % of the working
days, the status for that month was ‘‘fully return to work’’
(f-RTW). From these data, we constructed a file where
each study participant had one of three possible statuses
each month for the 24-month follow-up: OOW, p-RTW or
f-RTW.
The primary outcome of this study was RTW fully and
partly, at the 12-month and 24-month follow-up.
Sample Size
The sample size calculations were based on the results
from a previous RCT on BI in low-back pain [29]. With a
power of 80 % and a significant level of 5 %, the total
number of participants needed for this study was calculated
to be 300.
Randomization and Blinding
The randomization was concealed and the patients were
randomized to either MI or BI, according to a computer-
generated randomization-list, which was set up by a
statistician at Uni Research Health (URH). The list was
stratified by age and gender. A research assistant, who was
not involved in the treatment, contacted URH and was
informed about which treatment the patient should receive.
There was no blinding to the treatment of therapists or
participants.
Statistical Methods
Descriptive statistics based on the groups for the 24-month
follow-up were performed (Fig. 3), in addition to a multi-
nomial logistic analysis to explore the relative risk (RR)
ratios for p-RTW and f-RTW between the groups every
month (Table 2). P values\0.05 was considered statisti-
cally significant. The analyses adhered to the ‘‘intention-to-
treat’’ principle. The data were analysed using SPSS 21.
Ethical Considerations
The research was carried out in compliance with the
principles in the Helsinki declaration. The Norwegian
Regional Ethical Committee and the Norwegian social
science data services approved the study [34, 35]. Personal
confidentiality was guaranteed and informed consent was
signed by each participant, with emphasis on the right to




The baseline characteristics of the patients are presented in
Table 1. The mean duration of sick leave by inclusion was
147 days (SD = 60.1). Due to the waiting time from
inclusion to baseline assessment (between one and
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2 weeks), 11 patients (3.9 %) were no longer sick-listed by
baseline. Education limited up to 12 years was more pre-
dominant in the MI-group (73.8 %) compared to the BI-
group (63.3 %). The dominant diagnoses in accordance
with ICPC-2 [36] were: low back pain L02/L03/L84/L86
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Fig. 3 Descriptive statistics on
work status in valid % of
multidisciplinary intervention
group (MI) and brief
intervention group (BI):
proportions fully returned to
work (f-RTW), partly returned
to work (p-RTW) for both
groups at each month for
24 months follow-up
Table 1 Demographic and
clinical characteristics by
baseline [number (n) and valid
percent (%)], divided by
intervention groups,
multidisciplinary intervention
(MI) and brief intervention (BI)
Variables MI (n = 141) n (%) BI (n = 143) n (%)
Demographic
Age (mean, SD) 40.9 (9.8) 41.6 (9.5)
Women 77 (54.6) 76 (53.1)
Married or cohabitant 107 (75.9) 110 (77.0)
Children
None 25 (17.7) 31 (21.7)
1–2 75 (53.2) 73 (52.5)
Level of education
Public school, 1–12 years 104 (73.8) 91 (63.6)
University/college,[12 years 24 (17.0) 28 (20.6)
Work related variables
Employment degree
Partial (C50 %,\100 %) 39 (28.3) 30 (25.4)
Full time 99 (71.7) 103 (74.6)
Working time
Shifta 47 (34.6) 52 (38.2)
Sick-leave degree
Partial (C50 %,\100 %) 51 (36.2) 52 (36.4)
Full-time 85 (60.4) 85 (59.2)
Job security: ‘‘Do you have a job to return to?‘‘
Yes 124 (91.9) 127 (92.0)
Demands at work
Physically demanding 76 (55.1) 74 (52.5)
Mentally demanding 40 (29.2) 28 (19.9)
a Working both day and night-time
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pain/fibromyalgia L18 (10.7 %) and shoulder pain L08/
L92 (7.8 %). The study-population was given a total of 51
different diagnoses. Of these, the L-group represented
84.2 %. There were no significant differences between the
intervention groups regarding sick-leave duration or dis-
tribution of the different medical conditions by baseline.
Return to Work
There were no differences between the MI-group and BI-
group on f-RTW during the follow-up period of 24 months.
The highest RR was 1.42 (95 % CI 0.87–2.33, p = 0.17),
which was in the 23rd month. In all of the other months, the
RR was closer to unity (Table 2, Fig. 3).
At 12 months of the follow-up, 63 patients (44.7 %) in
the MI-group and 64 patients (44.8 %) in the BI-group
were f-RTW. The corresponding numbers at 24 months
were: 60 (42.6 %) in the MI-group and 52 (36.6 %) in the
BI-group.
In three of the first 7 months after baseline, significantly
more patients were p-RTW in the MI-group compared to
the BI-group. The highest RR was at the seventh month:
RR = 2.31 (95 % CI 1.19–4.51, p = 0.01). The corre-
sponding numbers for the second month was: RR = 1.86
(95 % CI 1.10–3.14, p = 0.02) and for the third month:
RR = 2.24 (95 % CI 1.28–3.91, p\ 0.01).
By 12 months, 59 patients (41.8 %) in the MI-group and
65 patients (45.5 %) in the BI-group were still OOW. The
corresponding numbers by 24 months were 63 (44.7 %) in
the MI-group and 68 (47.6 %) in the BI-group.
Discussion
In this study of patients on long-term sick leave due to
musculoskeletal pain, there were no significant differences
on RTW between the patients who received MI or the
patients receiving BI at 12 months or 24 months of the
follow-up. However, patients in the MI-group returned to
work faster than patients in the BI-group. This is illustrated
by the differences between the groups in proportions fully
out of work (OOW): At 3 months of the follow-up, the
proportion OOW in the MI-group was reduced to 48 %,
while in the BI-group it was slightly increased to 61 %
compared to the baseline levels.
A number of factors prolong musculoskeletal pain.
Some are obviously related to the individual, others to the
workplace [37] or to compensation systems [38]. Mul-
tidisciplinary interventions comply with the possibility that
barriers to work-participation exist at multiple levels and
have proven beneficial to facilitate RTW in low back pain
[23]. As psychosocial factors predict the long-term inca-
pacity of musculoskeletal disorders [39], interventions
focusing on these aspects should be of clinical value.
In our study, the MI-group received a more compre-
hensive approach, which included more therapist time, one
Table 2 Partly return to work
(p-RTW) and fully return to
work (f-RTW) for the
Multidisciplinary Intervention
group compared to the Brief
Intervention group (reference
group)
Months follow-up p-RTW f-RTW
RR 95 % CIa RR 95 % CIa
1 1.45 0.88–2.39 1.07 0.44–2.56
2 1.86 1.10–3.14* 1.07 0.53–2.18
3 2.24 1.28–3.91** 1.15 0.61–2.18
4 1.53 0.87–2.68 1.13 0.62–2.03
5 1.26 0.70–2.28 0.92 0.53–1.60
6 1.40 0.75–2.61 0.85 0.50–1.45
7 2.31 1.19–4.51* 1.11 0.66–1.87
8 1.90 0.97–3.72 0.98 0.59–1.64
9 1.61 0.77–3.37 0.93 0.57–1.54
10 1.67 0.77–3.61 1.18 0.72–1.95
11 1.62 0.75–3.53 1.27 0.78–2.09
12 1.60 0.74–3.46 1.10 0.67–1.81
13–23 Results not reported
24 0.85 0.42–1.71 1.25 0.75–2.06
Differences between the groups were estimated by multinomial regression analysis with ‘‘fully out of
work’’ as reference category. Risk Ratio (RR), 95 % Confidence Interval (CI) with p values are presented
a Indicates p value
* p value\0.05; ** p value\0.01
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more profession, more focus on psychosocial factors, in
particular work and workplace adaptions, compared to the
BI-group. The 2 h difference in therapist time might con-
tribute to improved results on p-RTW in the MI-group. The
MI also applied the ISIVET, which was constructed to
improve patient-therapist communication, facilitate patient
and therapist insight in the entirety of the situation, and
improve the patient’s autonomy and thereby, their
engagement in their own rehabilitation. The ISIVET aimed
to raise awareness of the value of work participation
through visualization of large areas in the star plot. It also
aimed to motivate patients to choose to work at least par-
tially, if not fully, in spite of their health complaints, with
the suggestion that work is healthy. If areas were small, the
possibility of alternative work was questioned by the
clinicians.
However, the MI did not increase the proportion of
patients who were f-RTW at 12 months or 24 months,
compared to the BI. However, the results of p-RTW are in
accordance with the conclusion of a recent Cochrane
review and of the findings of Loisel and his co-workers,
where a combination of a clinical intervention and an
occupational intervention was associated with a faster
RTW [40, 41]. The workplace intervention in the MI-group
was limited to the discussion and planning of workplace
adaptions between the patient and the team at the clinic.
The patient was responsible for initiatives at the workplace,
which was part of the patient-oriented coping strategy for
the MI.
The MI-group improved faster than the BI-group on
mental and physical symptoms, functional ability and
coping, but these results are published elsewhere [42].
The treatment of musculoskeletal pain is primarily given
by the GP but more complex cases are eventually referred
to the specialist health care [7, 20]. In this study, the GPs
who referred the patients did not know that their patients
might be enrolled in a clinical study. It is reasonable to
assume that our study-population is regarded by the GPs as
difficult to treat, as they were referred to specialist health
care and on long-time sick leave with musculoskeletal
pain, which in itself gives a poor prognosis. This might
explain the relatively low RTW-proportion in both groups.
It might also explain why it was difficult to achieve better
results, even with a more comprehensive approach and in
spite of improvements in health, coping and function
abilities, as described in an earlier paper [42].
A possibility that the patient is determined not to go
back to work or, for some reason, do not want to return to
their former workplace represents information that is not
necessarily accessible to the therapists. The majority of the
participants had low education and physically demanding
jobs, thereby representing mostly blue-collar workers with
fewer opportunities to find alternative work. This might
also contribute to the low proportions of RTW in this study.
The Norwegian sickness compensation system offers
100 % salary compensation from day one for up to a year.
After that period, the patient is covered by 66 % com-
pensation of salary through a rehabilitation allowance or
disability pension. This generous compensation system
might undermine the process of RTW through weak eco-
nomic incentives for the patients to get out of sick leave in
both groups.
The MI-group had a total of three sessions with thera-
pists during a three-month period and the BI-group had two
sessions. Given that these patients were on long-time sick
leave, it was perhaps too optimistic to hypothesize that a
limited intervention would increase RTW extensively.
Limitations and Strengths of the Study
The primary strengths of this study constitute the study
design with the randomization giving comparable groups,
and the relatively large sample included. Secondly, the use
of register data, leaving us with information on work par-
ticipation and sickness-compensation every month for
24 months of the follow-up for all of the patients included.
Furthermore, both treatments were based on written man-
uals and were easy to describe. Different teams did the BI
and the MI, reducing the possibility of mixing the two
methods. The BI-method was well known to the therapists
involved, and they had recently been videotaped and quality
assured in performing BI in another trial [43]. The therapists
performing the new MI-method practised regular meetings
and supervision to ensure adherence to the protocol and
equal practice of the method. The sickness-certificates were
prescribed by the GP’s and not by the physicians in the
study, reducing the possibility of a biased prescription from
therapists in the study. Finally; the drop out of treatment
was low in both groups indicating that the treatment is
feasible in clinical practice and that the results are reliable.
Some limitations should also be mentioned. First of all;
there were many similarities in the two treatment methods
and this could influence the possibility to come out with
significant differences in the outcome. Both were based on a
non-injury- and a bio-psychosocial model in pain assess-
ment, and both practised patient education. Furthermore,
both methods had an intervention limited to the individual
level; the patient. We could therefore not explore the effect
of environmental factors, nor could the therapists involve a
third part directly, which might have been valuable in the
process considering the significance of psychosocial factors
in chronic pain [4]. The occupational intervention in MI was
limited to the assessments of different aspects of the work-
situation and the discussion with the patients on possible
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fields of action, while the follow-up on the eventual work-
place interventions was the patient’s own responsibility.
This might not be sufficient to achieve actual changes.
External support with RTW-planning and process might
have improved the results as there is evidence that work-
place intervention improves time until first and lasting RTW
among workers with musculoskeletal disorders [41]. In the
BI-group, there were fewer and more experienced therapists
compared to the MI-group. If the therapists in the MI had
less confidence of their role due to less experience, it might
have influenced the interaction with the patient and trough
this, the outcomes, as there is evidence that what the doctor
and other health professionals say and do has a powerful
influence on outcomes [44]. There was no use of audiotap-
ing to ensure adherence to the protocol in this study and
there was no blinding of patients or therapists of practical
reasons. The patients knew they would get one out of two
possible interventions. Both were given in the specialist
health care and both were comprehensive compared to
ordinary services patients experience in the health care
system. The lack of blinding of the patients might therefore
be a limited weakness to this study. And finally, multiple
analyses were performed increasing the risk of finding sig-
nificant differences by coincidence. However, the results on
p-RTW showed a continuous trend towards differences in
the first 14 months. This trend supports the validity of the
three significant p values.
Concluding Remarks
A comprehensive MI focusing on work and psychosocial
factors could not increase RTW at 12 months and 24 months
in patients with chronic musculoskeletal pain, when com-
pared to the effect of a less resource-demanding BI. However,
the MI hastened the return to work process through the
increased use of partial sick leave during the first months of
the follow-up, compared to the BI. Longer treatments that
more actively involve the workplace, combined with struc-
tural changes in sickness compensation and labour marked,
might be necessary to decrease the proportion of patients on
long-term sick leave for musculoskeletal pain.
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Objective: To assess the predictive effect of a mul-
tidisciplinary intervention programme, pain, work-
related factors and health, including anxiety/de-
pression and beliefs, on return-to-work for patients 
sick-listed due to musculoskeletal pain. 
Design: A randomized clinical study. 
Methods: A total of 284 patients were randomized 
to either a multidisciplinary intervention program-
me (n = 141) or to a less resource-demanding brief 
intervention (n = 143). Work participation was es-
timated monthly from register data for 12 months. 
Return-to-work was defined as increased work par-
ticipation in 3 consecutive months. 
Results: In the adjusted model, return-to-work by 3 
months was associated with a multidisciplinary in-
tervention programme (odds ratio (OR) = 2.7, 95% 
confidence interval (95% CI) = 1.1–6.9), the factor 
“belief that work was cause of the pain” (OR = 2.2, 
95% CI = 1.1–4.3), anxiety and depression (OR = 0.5, 
95% CI = 0.2–0.98), and by an interaction between 
the multidisciplinary intervention and perceived 
support at work (OR = 0.3, 95% CI = 0.1–0.9). At 12 
months, only duration of sick leave was associated 
with return-to-work (OR = 0.6, 95% CI = 0.5–0.8).
Conclusion: Multidisciplinary intervention may has-
ten return-to-work and benefit those who perceive 
low support at work, but at 12 months only duration 
of sick leave at baseline was associated with return-
to-work.
Key words: multidisciplinary rehabilitation; return-to-work; 
sickness absence; sick leave; randomized clinical trial; prog-
nostic factors; musculoskeletal pain.
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Musculoskeletal pain is a major cause of sickness absence and work disability worldwide. In Wes-
tern countries, painful disorders of the back, neck and 
upper limbs are the most frequently reported causes, 
with work disability, long-term absence and perma-
nent disability as consequences (1). The prevalence of 
sick certification and incapacity benefits due to these 
conditions has increased substantially in most Western 
countries in recent decades (2), while, in Norway, 
approximately half of all sickness absences are due 
to musculoskeletal pain (3). Most of these conditions 
are non-specific with little objective pathology, but 
research has revealed an extensive psychiatric and 
somatic comorbidity in this patient group (4). In a 
cohort of 635 patients on long-term sick leave, 55% 
had psychiatric-somatic comorbidity, with the combi-
nation of fibromyalgia/myalgia and depression being 
the most frequent (5).
Pain is a multidimensional phenomenon, compri-
sing biological, psychological, social and existential 
elements. Thus, a number of predictors have been 
associated with the development and persistence of 
muscular pain. Some of these are work-related, such as 
physical demands at work or low job satisfaction, while 
others are psychiatric and affective risk factors, such 
as anxiety, expectations, fear avoidance or low mood 
(6, 7). To date, there is general consensus that chronic 
musculoskeletal pain conditions are multi-causal and 
comorbid (8), with multidisciplinary treatment being 
a recommended approach in the treatment of chro-
nic pain (9, 10). The effectiveness of treatment with 
regards to health and quality of life could, however, 
differ from its effects on occupational outcomes. The 
literature on occupational outcomes has focused more 
on identifying predictors for disability than RTW 
among these patients (11, 12). Systematic reviews of 
the effectiveness of RTW programmes have concluded 
that knowledge, psychosocial, physical and work con-
ditioning, possibly combined with relaxation exercises, 
are effective treatment components (12, 13). Studies 
of predictors of RTW have identified factors associa-
ted with the patient (functional ability, pain intensity, 
beliefs and expectations about recovery, RTW and low 
levels of education), the therapists (healthcare provider 
type, communication in therapy) and work (physical 
demands at work, job satisfaction, having unskilled 
work) (14, 15). In addition, depressive symptoms are 
associated with prolonged sick leave (16). 
The process of RTW following a period of long-
term sick leave reflects the complexity of the clinical 
picture, as medical, psychological, work and social 
factors often need to be addressed. This complies 
with the biopsychosocial model of disability. A mul-
tidisciplinary approach is recommended, but there is 
still no consensus on the content or dosage of these 









































194 R. Brendbekken et al.
about the predictors of the effect of multidisciplinary 
programmes on RTW is needed (12) in order to tailor 
interventions and possibly avoid applying resource-de-
manding programmes to individuals who might benefit 
to the same extent from a more limited intervention. 
A major motivation for this paper was the desire 
to analyse predictors for a more sustainable RTW on 
an individual level, with RTW defined as increased 
work-participation in 3 consecutive months, and to 
determine whether the 2 interventions had different 
effects on RTW defined in this way. In addition, the 
analysis aimed to determine whether patient- or work-
related factors, measured at baseline, could predict 
(sustainable) RTW by 3 and 12 months’ follow-up. 
Former publications from this study have examined 
differences in improvements in health, physical fun-
ctioning, coping and RTW between groups at 3 and 12 
months’ follow-up (17, 18).
The aims of this study were, therefore (i) to assess 
the predictive effect of a multidisciplinary interven-
tion (MI) vs the active comparator and less resource-
demanding brief intervention (BI) on RTW in patients 
with long-term musculoskeletal pain problems; and 
(ii) to assess whether RTW in this group of patients 
is predicted by work-related factors and/or subjective 
experience of pain and health.
METHODS
Design
The study was a randomized clinical trial with a 12-month 
follow-up period, exploring the effect of 2 different interven-
tions (MI and BI), including possible predictive factors on 
RTW, at the 3- and 12-month follow-up stages. The effects of 
the interventions on sick leave, RTW and secondary outcomes 
have been published elsewhere (17, 18). 
Trial registration. The trial was registered at the US National 
Library of Medicine’s ClinicalTrials.gov (http://www.clinical-
trials.gov), registration number NCT01346423.
Participants
A total of 284 patients, with a mean age of 41.3 years, of whom 
53% were women, were randomized to either MI (n = 141) or 
BI (n = 143) (Fig. 1). They were recruited from a list of patients 
who were on sick leave due to musculoskeletal pain and who 
were referred to the Department of Physical Rehabilitation, 
Innlandet Hospital Trust, Norway, in the period 2011–2013. 
Patients were referred by their general practitioner (GP) who had 
no knowledge that their patient might be enrolled on a clinical 
trial. Inclusion criteria were: age 20–60 years, at least 50% sick 
leave for no longer than 12 months due to musculoskeletal pain, 
and at least 50% employed. Exclusion criteria were: pregnancy, 
current cancer, osteoporosis, recent physical trauma/injury, 
serious mental illness, rheumatic inflammatory diseases, not 
capable of understanding and speaking Norwegian, or being 
involved in an ongoing health insurance claim. 
On inclusion, all participants completed a comprehensive 
set of questionnaires before they received baseline treatment. 
Study context
All lawful residents of Norway are included in the Norwegian 
public insurance system. This system, which provides health 
service benefits and pensions, is administered by the Norwegian 
Welfare and Labour Administration (NAV). When a worker 
is certified sick by their GP, the workers’ compensation pro-
gramme, administered by the NAV, provides 100% coverage 
for lost income from day 1 until the person can work again, for 
up to 52 weeks. The first 16 days are covered by the employer. 
After 1 year, the NAV covers long-term rehabilitation benefits 
or a disability pension, equating to approximately 66% of the 
person’s former income. These benefits can also be combined 
with work if the disability constitutes a minimum of 50%.
Multidisciplinary intervention programme 
The MI included 3 consultations at the outpatient clinic: at base-
line, after 2 weeks and after 3 months. The baseline assessment 
was the most comprehensive part, lasting approximately 3.5 h. 
The patient met each of the 3 members of the multidisciplinary 
team in succession, with each therapist assessing different as-
pects of the patient’s health and work situation, as follows. The 
social worker interviewed the patient about their work situation, 
family life, social life, education and economics. The physician 
interviewed the patient about their former and present health, 
and that of their family, and conducted a physical examination, 
which concluded with a diagnosis according to the International 
Classification of Diseases, 10th edition (ICD-10). The physioth-
erapist assessed the patient’s musculoskeletal problems and 
conducted a physical examination. In addition, the social worker 
and the physician collaborated with the patient using the novel 
Interdisciplinary Structured Interview with a Visual Educatio-
nal Tool (ISIVET) (17). The ISIVET comprises a manual and 
2 star plots with 7 axes. The first star plot, named “Working 







Assessed for eligibility  
(n=534) 
MI baseline assessment: n=141 
Treatment dropout: n=0 
BL-Q return: n=138 
BI two-week follow-up: n=128 
Treatment dropout: n=15 
BI baseline assessment: n=143 
Treatment dropout: n=0 
BL-Q return: n=141 
MI two-week follow-up: n=137 
Treatment dropout: n=4 
 
MI 3-month follow-up: n=134  
Treatment dropout: n=7 
Randomized  
(n=284) 
Not eligible (n=250) 
   Not meeting criteria (n=107) 
   Declined to participation (n=100) 
   Not possible to reach by phone (n=43) 
Allocated to BI 
(n=143) 





Fig. 1. Allocation and treatment flowchart. BL-Q: baseline questionnaire; 
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situation, while the second star plot, named “Quality of life”, 
evaluates 7 aspects of health and social life. The evaluation itself 
involves a scoring process that results in a coloured area for each 
of the 2 star plots, thereby visualizing the resources (coloured 
area) and the challenges (non-coloured area) connected to the 
work and life situation. In this study, the 2 figures with their 
areas were central when the team and the patient, at the end of 
the baseline consultation, were evaluating the situation in order 
to make a rehabilitation plan. The main aim of the MI was to 
strengthen the patient’s motivation and ability to make changes 
in their own life and, in particular, choose activities and RTW 
in spite of the pain problems. Details of the ISIVET method are 
given in this randomized clinical trial (RCT) (17). 
The patient had a follow-up with the physiotherapist after 2 
weeks and with the whole team after 3 months. Both follow-
ups lasted approximately 1 h and included working through the 
ISIVET once more, leading to an evaluation and, eventually, 
adjustment of the rehabilitation plan. The total face-to-face-time 
spent with the patient during the MI was 5.5 h.
Brief intervention programme 
The BI comprised 2 sessions: a baseline session lasting ap-
proximately 2.5 h, including separate consultations with a 
physician and a physiotherapist, and a 2-week follow-up with 
the physiotherapist for approximately 1 h. The BI applied in this 
study was based on a study by Molde Hagen (19). BI program-
mes have proven beneficial for low back pain, neck pain and 
fibromyalgia/widespread pain (20, 21). 
The BI is based on a non-injury model, whose goal is to reduce 
fear and concern, as well as help the patient to stay active despite 
pain, unless serious pathology is identified, emphasizing the fact 
that the body is a strong and robust structure and that return to 
normal activity is beneficial. Essential features of the method 
include giving the patient time to express problems, worries 
and thoughts, followed by a thorough medical, educational 
examination, where any somatic findings are explained to the 
patient. The patient is informed about the positive prognosis 
and the importance of staying active. The total face-to-face-time 
spent with the patient during the BI was 3.5 h.
Instruments and outcome measures
The comprehensive questionnaires at baseline comprised de-
mographic variables, information on education and different 
aspects of work, self-ratings on health, fitness and physical 
activity, information related to the sick certification, and the 
duration and initial/actual extent of sick leave. The clinically 
validated questionnaires described below were applied.
The Subjective Health Complaints (SHC) inventory is a relia-
ble instrument measuring somatic and psychological complaints 
over the previous 30 days using 29 questions rated on a 4-point 
scale (from 0 to 3) (22). The instrument has 5 subscales: “mus-
culoskeletal complaints” (8 items), “gastrointestinal problems” 
(7 items), “pseudoneurological problems” (7 items) and “flu” 
and “allergy” symptoms (7 items in total), in addition to a total 
score (SHC total), with a maximum value of 87 indicating the 
highest possible level of complaints that can be measured by 
this instrument. The subscale “musculoskeletal complaints” 
correspondingly has a maximum value of 24. Cronbach’s 
alpha for musculoskeletal complaints = 0.65, gastrointestinal 
problems = 0.71, pseudoneurological problems = 0.70, flu = 0.65, 
allergy = 0.48. 
The Hospital Anxiety and Depression Scale (HADS) asses-
ses anxiety and depression disorders (23). HADS consists of 
14 items that create subscale scores for anxiety (7 items) and 
depression (7 items) and a sum-score for both scales. The score 
for each subscale is calculated by adding the scores of the 
individual items (0–3) and ranges from 0 (good) to 21 (poor). 
Only the sum-score anxiety/depression was used in this study, 
and Cronbach’s alpha for this scale was = 0.86.
The Eysenck Personality Questionnaire-Nordic (EPQ-N) is 
a 12-item true-false questionnaire measuring neuroticism as a 
personality trait. The maximum score of 12 indicates a high 
degree of neuroticism. EPQ-N is derived from the 90-item EPQ 
(24), which measures neuroticism, psychoticism and extrover-
sion. Cronbach’s alpha for EPQ-N=0.84.
The Chronic Pain Acceptance Questionnaire (CPAQ) is a 
20-item assessment divided into 2 subscales: pain willingness 
(9 items) and activities engagement (11 items). The scores are 
set according to a numerical scale from 0 to 6 (highest degree 
of willingness or engagement), with the CPAQ sum has a 
maximum score of 120, indicating the highest possible level of 
willingness to tolerate pain and engage in activities measured by 
this instrument (25). Cronbach’s alpha for CPAQ sum= = 0.64, 
pain willingness = 0.81, activities engagement = 0.84.
Physical burden of work and psychological burden of work 
were assessed by the question: “Do you experience your work 
as a physical (correspondingly psychological) burden?” The 3 
possible answers (yes, no, some) were dichotomized into “yes/
some” = 1 and “no” = 0. 
Perceived support at work was measured by 6 items from 
Theorell, while answers were made using a 4-point numerical 
scale from minimum support to highest degree of support (1–4), 
with a maximum score of 24, indicating high support at work 
from leaders and colleagues (26). Cronbach’s alpha for support 
at work = 0.82.
Burden of work was measured as the demands/control fraction 
of Karasek et al. (26), including questions on job demands (5 
items) and questions on job control (decision latitude). The job 
control scale is the sum of 2 subscales: skill discretion (4 items) 
and decision authority (2 items). The answers are given on the 
range of 1–4, where 4 represents the most burdensome situation. 
Cronbach’s alpha for job demands = 0.73, skill discretion = 0.55 
and decision authority = 0.78.
 Regarding cause of the pain, the study participants were asked 
about what they believed was the cause of the pain problem, 
with the possibility of choosing a specific cause (e.g. actual 
work, strain at home, injury, leisure activity, incorrect treatment, 
deformity of the body or just “don’t know”). 
Return-to-work
The national register data was used to define the work/social 
insurance status in each calendar month after inclusion in the 
trial. The register data provided follow-up data on every par-
ticipant in both treatment groups for 12 months of follow-up, 
as well as information on the GP diagnosis that led to sick 
certification at baseline. Every month of the follow-up period, 
each participant was either out of work, partly working or fully 
working. At baseline, due to inclusion criteria, they were either 
out of work or partly working. The status of every follow-up 
month was compared with the status in the baseline month for 
every participant and defined a “success month” as a month 
with increased work participation compared with the baseline, 
while a “non-success month” was a month with unchanged or 
decreased work participation compared with the baseline. If a 
person had 3 consecutive “success month” statuses, this was 
defined as RTW, with the first out of the 3 months defined as 
the RTW month. 
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Statistical analyses
The odds of RTW within 3 and 12 months, respectively, were 
analysed using binary multiple logistic regression models, 
including all the following a priori selected, independent 
variables (1–4):
1. Intervention variable (MI = 1 and BI = 0).
2. Variables that were dichotomized by splitting the median 
score (above median score = 1, median score and below = 0): 
• Subjective health complaints (SHC total scale)
• Anxiety and depression (HADS)
• Neuroticism (EPQ-N)
• Acceptance of chronic pain (CPAQ)
• Muscular pain (SHC musculoskeletal subscale)
• Support at work 
• Burden of work (Karasek & Theorell).
3. Variables dichotomized to either yes or no by the given 
answers: 
• Physically demanding work
• Psychologically demanding work
• Whether the study participant believed that work was the 
cause of the pain.
4. Duration of sick leave was categorized into: 0–91; 92–153; 
154–213; and 214–365 days. 
For adjustment, the models also included sex and age (20–29; 
30–39; 40–49; 50–60 years). Each predictor variable was asses-
sed for interaction with the intervention in the models according 
to hierarchical elimination. The models’ goodness of fit was 
tested by the Hosmer-Lemeshow test. The significance level 
was set at 5% for all tests. The odds ratios (ORs) with 95% 
confidence interval (95% CI) are reported. 
RESULTS
Patients’ characteristics 
Baseline characteristics are shown in Table I. The 
mean duration of sick leave by inclusion was 147 
days (SD 60.1 days). As there was some waiting time 
(1–2 weeks) from inclusion to baseline assessment, 8 
patients (MI = 2, BI = 6) were no longer certified sick, 
but worked full-time at baseline. These patients were 
included in the analyses as non-RTW as they were 
unable to increase their degree of work participation 
compared with baseline. 
Diagnosis at baseline
The dominant diagnoses according to the International 
Classification of Primary Care 1998 (ICPC-2) (27) 
were low back pain (39.5%), neck pain (12.1%), wi-
despread pain/fibromyalgia (10.7%) and shoulder pain 
(7.8%). The sample comprised a total of 51 different 
diagnoses, of these 238 (83.8%) were musculoskeletal 
diagnoses, while 14 (4.9%) were psychiatric diagnoses, 
11 (3.9%) were neurological diagnoses, and 21 (7.4%) 
were other diagnoses. However, all patients were re-
ferred because of musculoskeletal pain problems. The 
ICPC diagnoses on the sickness certificates were av-
ailable when we received the social insurance register 
data at the end of the study. 
Return-to-work
By the 3-month follow-up stage, 25.5% (n = 36) in 
the MI group and 20.3% (n = 29) in the BI group were 
categorized as RTW (p = 0.29). By the 12-month 
follow-up, the proportions were 63.8% (n = 90) and 
58.7% (n = 84), respectively (p = 0.38).
Predictors for return-to-work
The adjusted OR for RTW within 3 months in the MI 
group, compared with the BI group, was 2.69 (95% 
CI: 1.06–6.85), while it was 1.13 (0.67–1.91) within 12 
months (Table II). RTW after 3 months was also signi-
ficantly associated with believing that pain was caused 
by work (OR: 2.17, 95% CI: 1.11–4.26) and with anx-
iety/depression (OR: 0.45, 95% CI: 0.20–0.98). There 
was an interaction between intervention and perceived 
support at work (OR: 0.24, 95% CI: 0.07–0.85), indi-
cating that those with low perceived support at work 
Table I. Baseline characteristics of participants (n = 284) 
divided according to multidisciplinary intervention (MI) and brief 
intervention (BI) 
MI (n = 141) BI (n = 143)
Age, years, mean (SD) 40.9 (9.8) 41.6 (9.5)
Level of education, mean (SD)
Public school, 1–12 years 104 (73.8) 91 (63.6)
University/college, > 12 years 24 (17.0) 28 (20.6)
Health variables, mean (SD)
Pain at rest, NRS (0–10) 4.75 (2.23) 4.45 (2.21)
Pain during activity, NRS (0–10) 6.62 (1.93) 6.26 (2.11)
HADS sum (0–21) 10.2 (6.0) 10.0 (6.6)
EPQ-N sum (0–12) 4.5 (3.1) 4.0 (3.3)
SHC sum (0–87) 20.1 (9.4) 18.4 (9.4)
SHC muscular (0–24) 10.6 (4.2) 10.1 (4.4)
CPAQ sum (0–120) 62.9 (15.3) 61.7 (15.1)
Sex, n (%)
Women 77 (54.6) 76 (53.1)
Number of sick leave days, n (%) 143.2 (56.6) 149.6 (62.9)
Work situation, n (%) 
Employment degree
Partial (≥ 50%, < 100%) 39 (28.3) 30 (25.4)
Full-time 99 (71.7) 103 (74.6)
Working time
Shifta 47 (34.6) 52 (38.2)
Extent of sick leave 
Partial (≥ 50%, < 100%) 51 (36.2) 52 (36.4)
Full-time 85 (60.4) 85 (59.2)
Job security: “Do you have a job to return to?” 
Yes 124 (91.9) 127 (92.0)
Demands at work
Physically demanding 76 (55.1) 74 (52.5)
Psychologically demanding 40 (29.2) 28 (19.9)
Work regarded as cause of the pain problem, 
n (%) 84 (59.6) 89 (62.2)
Positive expectations regarding RTW, n (%) 82 (59.9) 82 (58.2)
NRS: numerical rating scale; HADS sum: Hospital Anxiety and Depression 
Scale total score; EPQ-N sum: Eysenck Personality Questionnaire-Nordic 
version total score; SHC sum: Subjective Health Complaints (Eriksen & Ursin) 
total score; SHC muscular: Subjective Health Complaints (Eriksen & Ursin) 
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benefitted significantly more from MI compared with 
BI (Table III). For RTW after 12 months, duration of 
sick leave was the only significant predictor (OR: 0.63, 
95% CI: 0.49–0.82). All interaction variables were 
eliminated from the 12-month model. Five baseline 
questionnaires (MI = 3, BI = 2) were never returned, 
and baseline information on these individuals were 
included as missing values.
DISCUSSION
By the 3-month follow-up, patients who received the MI 
seemed more prone to RTW than patients who received 
the BI, adjusted for confounders and the other study 
factors. This result was not found 12 month follow-up. 
RTW was also predicted by believing that pain was 
caused by work, while anxiety and depression was a 
negative predictor. The subgroup reporting low support 
at work (LSW) (lower than median) benefitted more 
from the MI, compared with the BI, with an OR for 
RTW = 4.2 (95% CI = 1.2–14.2). This was the only study 
factor that interacted significantly with the intervention. 
By the 12-month follow-up, the duration of sick leave 
at baseline was a negative predictor for RTW. 
Both interventions in this study are based on the 
biopsychosocial model of disability (28) and both 
practiced patient education. The MI, which had an 
additional 2 h therapist time and a social worker in 
the team, was a more comprehensive intervention 
than the BI, focusing on work in particular, as well as 
psychosocial factors and communication. 
Reviews on the efficacy of MIs on RTW, compared 
with other treatment modalities, have shown conflicting 
results (10, 12, 13, 29). However, our findings are in 
accordance with studies in which a clinical intervention 
combined with an occupational intervention is asso-
ciated with a faster RTW (30, 31). A recent Cochrane 
review concluded that workplace interventions reduce 
the time to RTW, as well as improve pain and functional 
status in workers with musculoskeletal disorders (32). 
This RCT found that the MI group improved more ra-
pidly than the BI group in terms of physical and mental 
symptoms, along with reporting less use of health servi-
ces and a better ability to cope (17). Van der Giezen et al. 
(33) found that interventions combining psychosocial 
aspects, health and work predicted RTW in chronic 
low back pain, which is in line with our results. On the 
other hand; the potential for increasing RTW rates by 
applying more extensive interventions, such as the MI, 
might be through the earlier mobilization of individuals 
who would have chosen to RTW at a later time, as the 
MI did not predict RTW by 12 months. From a 1-year 
perspective, this effect of a hastened RTW represented 
sustainable work participation.
Improved communication between patients and 
therapists can improve coping and outcomes (34). The 
application of the ISIVET could have contributed to 
our results on RTW, by supporting and encouraging the 
patient to choose work in spite of pain problems when 
areas on the star plot were large, or to apply for alter-
native work or employment when areas were small. 
The therapists argued that work is generally beneficial 
for health and well-being. The MI also included initia-
tives directed at improving the work situation, where 
relevant. These aspects of the MI may also explain 
why individuals with LSW benefitted more from an 
MI than a BI in terms of RTW. 
More therapist time has proven beneficial in treat-
ments for psychiatric disorders (35), but the differences 
are comprehensive. The additional 2 h of therapist time 
in the MI compared with the BI is unlikely to explain 
RTW differences between the groups on its own, given 
that the patients were mainly chronic pain patients with 
complex problems. 
Table II. Adjusted odds ratios (OR) and 95% confidence interval 
(95% CI) for return to work (RTW) by 3- and 12-month follow-up
3-month 
follow-upj 12-month follow-upj
OR 95% CI OR 95% CI
Intervention 2.69 1.06–6.85 1.13 0.67–1.91
Psychological burden of worka 0.76 0.38–1.53 1.16 0.63–2.12
Physical burden of worka 2.28 0.85–6.17 1.70 0.79–3.63
Pain caused by workb 2.17 1.11–4.25 1.29 0.75–2.22
Workloadc,a 0.95 0.50–1.82 0.66 0.38–1.14
Support at worka 1.64 0.65–4.12 1.08 0.62–1.87
Subjective Health Complaints (22)a 1.33 0.58–3.03 0.68 0.32–1.42
Anxiety and depressiond,a 0.45 0.20–0.98 0.70 0.36–1.37
Neuroticisme,a 0.72 0.33–1.55 0.73 0.38–1.41
Acceptance of chronic painf,a 1.30 0.69–2.47 1.22 0.71–2.11
Muscular paina 0.82 0.38–1.78 1.77 0.88–3.59
Duration of sick leaveg 0.90 0.66–1.22 0.63 0.49–0.82
Intervention and support at workh 0.24 0.07–0.85 Eliminated
Agei 1.07 0.78–1.47 0.89 0.68–1.17
Sex 0.84 0.45–1.57 1.00 0.58–1.74
aContinuous variable dichotomized by a split at the median score: below 
median = 0, above median = 1. bStudy participant believes work is cause of the pain 
(yes = 1, no = 0). cWorkload = work demands/work control (Karasek & Theorell). 
dHospital Anxiety and Depression Scale total score. eEysenck Personality 
Questionnaire-Nordic. fChronic Pain Acceptance Questionnaire. gCategorized 
into 4 groups: 0–91; 92–153; 154–213; and 214–365 days. hInteraction 
term; the other interaction terms were eliminated from the model, as none of 
the other factors had a statistical significant interaction with the intervention
iCategorized into 4 groups: 20–29; 30–39; 40–49; and 50–60 years.
jGoodness-of-fit (Hosmer-Lemeshow) for the model: 3 months, p = 0.94, 12 
months, p = 0.45.
Table III. Return-to-work (RTW) at 3-month follow-up, split by 











MI n (valid %) 12 (23.1) 21 (26.6) 40 (76.9) 58 (73.4)
BI n (valid %) 16 (26.2) 12 (15.4) 45 (73.8) 66 (84.6)
aMissing = 3. bMissing = 11.
MI: multidisciplinary intervention; BI: brief intervention. 
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supervision to ensure adherence to the protocol and 
consistent practice of the method. The sick certificates 
were issued by the GP in cooperation with the patient, 
rather than by physicians on the study, reducing the 
possibility of a biased diagnosis. Finally, the dropout 
rate from treatment was low in both groups, indicating 
that the treatment was feasible in terms of clinical 
practice and that the results are reliable. 
Education was omitted as an adjustment factor be-
cause information on education was reported inaccurate 
on questionnaires for 12% (MI = 7%, BI = 16%) of the 
study sample. This might be a weakness of this study, 
as level of education can be associated with outcomes 
(2). However; the possibility that the 2 groups differ sig-
nificantly in terms of education level, is reduced by the 
randomization. Another limitation concerned the simila-
rities in the 2 treatment methods. Both were short-term 
interventions based on a non-injury and biopsychosocial 
models for pain assessment, and both practised patient 
education. There was no use of audiotaping in order to 
ensure adherence to the protocol in this study; nor was 
there any blinding of patients or therapists for practical 
reasons. Audiotaping might have strengthened the study 
due to quality control of treatment teams. 
Conclusion
The MI, focusing, in particular, on the work situation, 
appeared to hasten RTW in patients who were certified 
sick with musculoskeletal pain, and to be beneficial 
for those who perceive LSW, compared with the BI. 
However, from a 1-year perspective, there was no 
difference between the MI and BI regarding RTW. 
Patients who believed work was the cause of their pain 
were found to RTW faster in both groups. Psychiatric 
comorbidity was a negative predictor for RTW at the 
3-month follow-up, as was duration of sick leave by 
baseline at the 12-month follow-up. 
The MI, as applied in this study, represents a novel 
approach. Further studies are needed to draw conclu-
sions about the effects of this method compared with 
those of BI. 
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Abstract
Background Musculoskeletal pain is associated with comor-
bidity, extensive use of health services, long-term disability
and reduced quality of life. The scientific literature on effects
of treatment for musculoskeletal pain is inconclusive.
Purpose The purpose of this study is to compare a mul-
tidisciplinary intervention (MI), including use of the novel
Interdisciplinary Structured Interview with a Visual
Educational Tool (ISIVET), with a brief intervention (BI),
on effects onmental and physical symptoms, functioning abil-
ity, use of health services and coping in patients sick-listed due
to musculoskeletal pain.
Method Two hundred eighty-four adults aged 18–60, referred
to a specialist clinic in physical rehabilitation, were random-
ized to MI or BI. Patients received a medical examination at
baseline and completed a comprehensive questionnaire at
baseline, 3 months and 12 months.
Results Both groups reported improvements in mental and
physical symptoms, including pain, and improved functioning
ability at 3 and 12 months, but the MI group improved faster
than the BI group except from reports of pain, which had a
similar course. Significant interactions between group and
time were found on mental symptoms (anxiety (p<0.05), de-
pression (p<0.01), somatization (p<0.01)) and functioning
ability (p<0.01) due to stronger effects in the MI group at
3 months. At 3 and 12 months, the MI group reported signif-
icantly less use of health services (general practitioner
(p<0.05)). At 12 months, the MI group reported better self-
evaluated capability of coping with complaints (p<0.001) and
they took better care of their own health (p<0.001), compared
to the BI group.
Conclusion The results indicate that the MI may represent an
important supplement in the treatment of musculoskeletal
pain.
Keywords Randomized clinical trial . Chronic
musculoskeletal pain .Multidisciplinary treatment .
Patient education tool
Introduction
Musculoskeletal pain conditions such as fibromyalgia and low
back pain are, in the majority of cases, unspecific and com-
posite [1]. Although non-malignant, they represent substantial
suffering and economic loss for the individual itself and for
the society due to frequent contacts with the health care sys-
tem, absence from work and reduced quality of life [2–6]. In
Norway, musculoskeletal diagnoses represent about 45 % of
the long-term sick leave [7]. Most of the patients have other
subjective health complaints as well, where pathological find-
ings are absent or substantially less than expected, compared
to the reported intensity of the complaints [8]. There is general
consensus in the literature that these conditions are multicaus-
al [9] and comorbid [8, 10, 11]. Psychological and social fac-
tors, as well as somatic pathology, influence chronicity and
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disability [12]. This indicates that the optimal treatment
should focus on several aspects of the patient’s life [1, 12,
13]. Improved incorporation of patient preferences into
treatment recommendations can improve adherence to
treatment and thereby improve the clinical outcomes
[14]. Multidisciplinary treatment is a well-accepted and
well-documented method to treat chronic pain [13, 15,
16], and education combined with physical exercise pro-
duces some positive effects in long-term follow-up for
fibromyalgia and musculoskeletal pain [13]. The
European guidelines for low back pain state that the
optimal content of multidisciplinary programs requires fur-
ther research, but behavioural treatment and stress manage-
ment are important components of these programs [1]. There
is, however, a lack of systematic content or description of
such, in many of these programs.
The aim of this study was to compare the effects of a mul-
tidisciplinary intervention (MI) and a brief intervention (BI),
on mental and physical health complaints, functioning ability
and coping in patients on long-term sick leave due to muscu-
loskeletal complaints. The study is part of a randomized clin-
ical trial (trial reg. nr. NCT01346423) where return to work
was the main outcome.
Material and Methods
Five hundred thirty-four patients with musculoskeletal pain
referred to a specialist outpatient clinic, at the Department of
Physical Medicine and Rehabilitation, Innlandet Hospital
Trust, Norway, between 2011 and 2013, were considered for
participation in the trial. Patients were referred from general
practitioners (GPs) in 48 municipalities in two different
counties in the south-eastern part of Norway. The inclusion
criteria were as follows: age between 20 and 60 years, at least
50 % sick leave due to musculoskeletal pain for less than
12 months and at least 50 % employed. The exclusion criteria
were as follows: pregnancy, current cancer, osteoporosis, re-
cent physical trauma/injury, serious mental illness, rheumatic
inflammatory diseases, not capable of understanding and
speaking Norwegian or being involved in an on-going health
insurance claim. Of the 534 patients, 250 were either not eli-
gible or excluded for different reasons. Two hundred eighty-
four (mean age 41.3 years, 54 % females) patients were in-
cluded in the study and randomized to either MI (n=141) or
BI (n=143) (Fig. 1). The patients included were referred from
136 different GPs who referred between one and eight patients
each.
Interventions
The two interventions were given by different teams and at
two different outpatient clinics.
The MI with the ISIVET
Baseline Treatment SessionA social worker, a physician and
a physiotherapist performed the MI. Initially, they consulted
the patient successively. Each consultation was two-parted:
First, an interview and, eventually, a physical examination
and, secondly, the use of ISIVET.
In the first part, the social worker interviewed the patient on
her/his social situation (family life, social life, education, eco-
nomics) and work situation, while the physician did a com-
prehensive interview covering past and present physical
and mental health for the patient and his/her family. The
physician also elaborated on coping and fear avoidance
in relation to the pain problems, in addition to a phys-
ical examination, concluding with a diagnosis according
to ICD-10. The physiotherapist assessed the musculo-
skeletal problems of the patient through interview and a
physical examination.
During the second part of each consultation, the therapists
used the ISIVET. The method is developed by the first author
(RB) and consists of two figures, a manual, a table for filling
out a rehabilitation plan and a list where possible rehabilitation
initiatives are categorized. Each figure is a star plot with seven
axes representing different variables (Fig. 2). Each axis has the
range from 1 (centrally) to 10 (peripherally). The patient
scored her/himself with assistance from the therapist and guid-
ing from the manual, on each variable on this numeric scale,
where B1^ indicates a maximum negative situation whereas
B10^ indicates an optimally positive situation. The manual
gives illustrating examples of the situation at different
levels. Patient and therapist read the manual together,
and through discussion, they identified the right score
for each variable and marked it on the actual axis in a
paper version of the figure. When all scores were complet-
ed, a line was drawn between the seven scores giving an area
in each of the two figures. The area under the lines was
coloured for better visualization for the patient as well as for
the therapists. Problem areas or challenges were demonstrated
as lack of colour, while existing resources stood out as
coloured area.
The first figure Bworking conditions^ included the
following variables: work-related stress, satisfaction with
job tasks, workload, collegial relationships, leadership,
degree of challenges at work and occupational partici-
pation. It was filled out during the consultation with the
social worker. The second figure Bquality of life^ in-
cluded the following variables: physical complaints,
psychological well-being, sleep, energy, physical activi-
ty, social participation and occupational participation
and was filled out during the consultation with the phy-
sician and the physiotherapist.
When the sessions with the three therapists were
completed, the whole team met briefly, sharing their
2 Int.J. Behav. Med. (2016) 23:1–11
findings and general impression of the patient and her/
his situation at work and at home. Possible barriers to
work participation, maintaining factors to the on-going
pain problems and, eventually, other important issues
were highlighted. The patient then joined the meeting
to a final discussion with the team on her/his situation,
health problems and work situation. The two figures
from the ISIVET were central when discussing possible
fields of actions. The patient decided ways to go for-
ward, and agreement on actions was written down in a
table and categorized according to the standardized pro-
tocol. These action items comprised the patient’s reha-
bilitation plan and were typically related to cognitive
assessment of health, as fear avoidance and catastrophic
thinking, lifestyle and, if relevant, family and work mat-
ters. Actions could also involve physical exercise or
increased daily physical activity. When leaving the clin-
ic, the patient received a paper copy of the figures with
the coloured areas and the rehabilitation plan listed as
points to be followed. A copy of the complete medical
3 months treatment session 
Treatment drop-out (n = 7)
3 months Q-follow-up
Return Q: n=112 (79.4%)
2 weeks treatment session 
Treatment drop-out: n=15
Baseline treatment session 
BI   (n=143)
Treatment drop-out: n=0
Return Q: n=141 (98.6%)
Baseline treatment session 
MI (n=141)
Treatment drop-out: n=0
Return Q: n=139 (98.6%)
2 weeks treatment session 
Treatment drop-out: n=4
Assessed for eligibility (screened)  
n= 534
Patients randomized (n= 284) to:
Multidisciplinary Intervention (MI) n=141
Brief Intervention (BI) n=143
250 patients were not eligible:           
- 100 did not want to   participate
- 43 unable to contact (by phone)
107 not meeting criteria:
- 40 not sick-listed
- 29 < 50% sick-listed
- 13 < 50% employed
- 11 sick listed > 1 year
- 5 on-going treatment another 
specialist
- 2 age > 60 years
- 2 pregnant
- 2 on-going insurance claim
- 1 did not speak Norwegian
- 1 osteoporosis
- 1 on-going cancer
3 months Q-follow-up
Return Q: n=95 (66.4%)
12 months Q-follow-up
Return Q: n=85 (60.3%)
ISIVET by phone: n=97 
(68.8%)
12 months Q-follow-up
Return Q: n=87 (60.8%)
Fig. 1 Flowchart of
participation, in treatment
sessions and questionnaires (Q)
follow-up
Fig. 2 Example of figure Bquality of life^ filled in three times
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record was sent both to the GP and the patient. The baseline
assessment lasted about 3.5 h.
After 2 weeks, the patient and the physiotherapist met for
about 1 h to evaluate the rehabilitation plan and work
through the ISIVET once more. New scores and new
areas were marked in the figures made at baseline, and
areas were coloured with a new colour (Fig. 2).
Visualization of delta areas in the star plot was matter of
attention and reflection. Previous advice and actions were
highlighted according to this, and adjustments in the re-
habilitation plan were eventually made.
After 3 months, the patient met with the whole team for
about 1 h to sum up the situation and evaluate the inter-
ventions so far. The ISIVET was worked through, and
new areas on the figures were coloured with a third col-
our. Eventually, they adjusted the rehabilitation plan.
At 12months follow-up, the physiotherapist contacted the
patient by phone to score the two figures in the ISIVET a
last time. This was a brief contact that lasted about
15 min.
To ensure adherence to the protocol and equal practice of
the method, the MI team had regular meetings for supervision
and discussions. Four physicians, all specializing in physical
medicine and rehabilitation, two social workers and four
physiotherapists did the treatment. The team members
were the same during the treatment course of one patient.
Audiotaping was not used.
The BI
BI is a standardized intervention based on the studies by
Indahl [17] and Molde Hagen [18], and details on the method
are described in the pioneer work of Indahl [10, 17].
BI comprised of two sessions. The baseline session lasted
about 2.5 h and included separate consultations with the phy-
sician and the physiotherapist. After 2 weeks, the patients had
a follow-up session with the physiotherapist for about 1 h.
The basic principle of the BI is the non-injury model, em-
phasizing the lack of any objective signs of injury [17, 19] and
the non-directive communication [20, 21]. BI has proven
more effective on return to work (RTW), health complaints
and functional ability, than usual care both for chronic low
back pain and non-specific muscular pain conditions [18,
20]. The goal is to reduce fear and concern through a thorough
medical examination with explanations of each step and edu-
cation about a physiological model on musculoskeletal pain.
Any somatic findings are explained. The patient is informed
about the good prognosis and the importance of staying
active.
A physician who was specialist in physical medicine and
rehabilitation and a physiotherapist did the BI. Both were
experienced in the method. Therapist treatment manuals were
written for the intervention, based on current guidelines [1]
and on the manuals used by Indahl andMolde Hagen [10, 18].
Audiotaping was not used. The physician had been
videotaped giving BI in another trial [22]. A copy of the med-
ical record was sent both to the GP and the patient.
Randomization and Blinding
The randomization was concealed, and patients were random-
ized to either MI or BI, according to a computer-generated
randomization list set-up by a statistician at Uni Research
Health (URH). URH received information on ID number,
gender and age, and a research assistant, not involved in the
treatment, contacted URH and was informed on which treat-
ment that the patient should receive. For practical reasons,
there was no blinding to treatment of therapists or participants.
Dropout from Randomized Treatment
Patients who dropped out of treatment were asked if they were
willing to continue filling out questionnaires and return them
by mail.
Questionnaires
The patients received the questionnaires by mail and filled
them out at baseline and at 3 and 12 months follow-up. The
following questionnaires were applied:
The Hospital Anxiety and Depression Scale (HADS) cov-
ered symptoms of anxiety and depression [23]. HADS
consists of 14 items, of which seven measures anxiety
and seven depressive symptoms. Scores are made on a
four-point Likert scale ranging from 0 (Bnot at all^) to 3
(Bvery often^) on symptoms experienced during the last
week, providing 21 as a maximum sum score for each
subscale. A cut-off score of eight and above is used as an
indication of possible, anxiety or depressive disorder.
The Hopkins SymptomChecklist-25 (HSCL-25) measures
psychological distress [24]. The instrument consists of 25
questions recording the presence and intensity of the most
common symptoms of anxiety, depression and somatiza-
tion. Severity is scored on a four-point Likert scale from 1
(not at all) to 4 (Bvery much/to a severe degree^), and a
mean score <1.75 is within normal range, while a score
≥1.75 indicates psychological distress in the need of
treatment.
The Norwegian Function Assessment Scale (Norfunk)
measures four aspects of physical function and three as-
pects of psychological function during the last week by
41 questions [25]. Physical function is related to the pa-
tient’s ability to walk/stand, hold/pick, lift/carry and sit.
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Psychological function covers the ability to be attentive,
communicate, work in team, handle responsibility, han-
dle challenges of daily life, deal with criticism, cope with
anger, communicate with others and to look/listen. The
answers are scored on a four-point Likert scale from 0
(Bno problems^) to 3 (Bnot able to do the activity^).
Subjective Health Complaints (SHC) inventory is a reli-
able instrument measuring somatic and psychological
complaints experienced during the last month [26]. It
contains 29 items covering the most frequent subjective
health complaints from different parts of the body.
Severity is scored on a four-point Likert scale from 0
(not at all) to 3 (Bseriously^). The instrument has five
subscales: musculoskeletal complaints, gastrointestinal
problems, pseudoneurological problems, flu and allergy
symptoms in addition to a total score (SHC total).
Pain was measured with a Numeric Rating Scale (NRS).
The patients were asked about mean pain in the back, the
neck, the foot and during activity, at rest and at night for
the last 14 days. The severity of pain was scored from 0
(Bno pain^) to 10 (Bworst possible pain^).
At 3 and 12 months, the patients were asked if they had
been treated by GP, chiropractor or physiotherapist or had
received other treatment during the last 3 months and, if so,
for how many sessions.
At 12 months, the patients were also asked about changes,
compared to 1 year ago, in complaints, general health, coping
with health complaints, ability to take care of their own health
and physical fitness. They were also asked about satisfaction
with the treatment. Answers were scored on a five-point Likert
scale from 1 (Bmuch better^) to 5 (Bmuchworse^) except from
patient satisfaction with treatment which was assessed on a
seven-point Likert scale from 1 (Bvery satisfied^) to 7 (Bvery
dissatisfied^).
Statistics
A mixed between–within-subjects analyses of variance with
one between-group factor (MI vs. BI) and one within-subjects/
repeated measures factor (baseline, 3 months, 12 months)
were conducted to assess the effect of the two interventions
on participant scores on depression, anxiety, somatization
(HADS and HSCL), functional ability (Norfunk) and health
complaints (SHC). The interaction effects (time × group) were
calculated, and when significant, such interaction effects indi-
cate different time courses for the two interventions.
Interaction effects were followed up by t tests for paired sam-
ples within each group. Cohen’s d was calculated between
baseline and 3 months follow-up and baseline and 12 months
follow-up using an online calculator (http://easycalculation.
com/statistics/effect-size.php) based on this formula: d=M1−
M2/(√(SD12+SD22)/2). Differences for outcomes between
the two interventions in scores on pain measured by NRS
were analyzed by Mann–Whitney U test for independent
samples at 3 and 12 months. Differences for outcomes in use
of health services, patient-evaluated health changes, coping
and satisfaction with treatment at 12 months were assessed
with x2 statistics or Fisher’s exact test. Sample size calcula-
tions were in accordance with RTW expectations, which are
part of this RCT but described in another paper, and based on
data from Hagen et al. [18]. The calculation was based on a
power of 80 % and a significant level of 5 % giving an N for
this study of 300.
Ethical Considerations
The study followed the Helsinki declaration and was approved
by the Norwegian Regional Ethics Committee in south-
eastern Norway [27] and by the Norwegian Social Science
Data Services [28]. Participants gave their informed consent
by signing the declaration of voluntarily participation before
entering in the study.
Results
Demographic and Baseline Data
The study population comprised 284 individuals (mean age
41.3 years, 53.9 % women). Two hundred seventeen (76.4 %)
of the patients were married or cohabitant, 195 patients
(68.7 %) reported education limited to primary school
(≤12 years), 56 patients (19.7 %) had no children, and 238
patients (83.8 %) reported 80 % employment or more. Mean
duration of sick leave during the 8-month period before entry to
the studywas 143 days (SD=56.6) in theMI group and 150 days
(SD=62.9) in the BI group. The dominant diagnoses in accor-
dance to ICPC-2 [29] were as follows: low back pain L02/L03/
L84/L86 (39.5 %), neck pain L01/L83 (12.1 %), widespread
pain/fibromyalgia L18 (10.7 %) and shoulder pain L08/L92
(7.8 %). The whole study population constituted 51 different
diagnoses, the L group representing 84.2 %. There were no
differences in pain diagnoses between the groups at baseline.
Lost to Follow-Up
The dropout of treatment was low in both groups (Fig. 1).
Return of questionnaires dropped to 60.3 % in the MI group
and 60.8 % in the BI group at 12 months (Fig. 1).
There were no significant differences in baseline scores
between returners and non-returners of questionnaires,
except from the score on HSCL depression where the
non-returners scored significantly lower (mean=1.47, SD=
0.46) compared to the returners (mean=1.60, SD=0.55), giv-
ing a p value <0.05 of the difference.
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Changes in Anxiety, Depression and Somatization
Anxiety and depression measured with HADS and so-
matization and depression measured with HSCL showed
a significant interaction between group and time, indi-
cating that the BI group and the MI group differed
significantly on these subscales (Table 1). By 3 months,
the MI group reported improvements on anxiety, depres-
sion and somatization (all p values <0.01) measured
with HADS and HSCL, while the BI group reported a
significant worsening on HADS anxiety (p<0.01) and a
smaller improvement on anxiety, depression and somatiza-
tion measured with HSCL (all p values<0.05) compared to
the MI group. However, at 12 months, the groups were simi-
lar, with both groups reporting significantly improvements on
all subscales.
Changes in Functional Ability
Functional ability measured with Norfunk showed a signifi-
cant interaction between group and time, indicating that the BI
group and the MI group had a significantly different time
course on the functional ability (Table 2). The MI group
had significant improvements from baseline to 3 months
on six of seven subscales and on the total score (all
p values <0.01), while the BI group had significant,
but weaker improvements on two subscales (p<0.05).
By 3 months, the Cohen’s d was larger on all items of
the Norfunk in the MI group compared to the BI group, which
had negative value on three subscales, indicating deteriora-
tion. By 12 months, both groups had significant improve-
ments from baseline, but with no significant differences be-
tween the groups.
Table 1 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on anxiety, depression and soma-
tization measured by the Hospital
Anxiety and Depression Scale
(HADS) and Hopkins Symptom
Checklist (HSCL)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
HADS anxiety
Baselined 5.59 (3.29) 5.51 (3.70)
3 monthse 4.82 (3.34)** 0.27 5.74 (4.12)** −0.02
12 monthsf 4.53 (4.25)** 0.24 4.79 (4.08)** 0.28 3.79 0.02
HADS depression
Baselined 4.58 (3.42) 4.50 (3.55)
3 monthse 3.83 (3.35)** 0.32 4.86 (4.11) −0.06
12 monthsf 3.71 (3.85)** 0.21 3.99 (3.65)* 0.23 10.89 <0.00
HSCL somatization
Baselined 2.01 (0.54) 1.95 (0.58)
3 monthse 1.74 (0.49)** 0.63 1.87 (0.70)* 0.15
12 monthsf 1.69 (0.57)** 0.61 1.73 (0.67)** 0.40 8.01 <0.00
HSCL anxiety
Baselined 1.47 (0.41) 1.45 (0.40)
3 monthse 1.35 (0.34)** 0.38 1.42 (0.43)* 0.17
12 monthsf 1.32 (0.39)** 0.40 1.33 (0.44)** 0.39 2.17 0.12
HSCL depression
Baselined 1.54 (0.48) 1.55 (0.56)
3 monthse 1.35 (0.38)** 0.50 1.50 (0.58)* 0.19
12 monthsf 1.39 (0.49)** 0.36 1.40 (0.59)** 0.38 4.14 0.02
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
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Changes in SHC
There were no significant interactions between group and time
for any of the SHC subscales (Table 3). This indicates that the
two interventions did not affect SHC differently. The Cohen’s d
was larger on all items by 3months in theMI group compared to
the BI group, and the changes from baseline to 3 months were,
overall, larger in the MI group by 3 months. By 12 months, the
Table 2 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on different aspects of functional
ability (Norfunk)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
Norfunk all items
Baselined 1.44 (0.28) 1.44 (0.30)
3 monthse 1.33 (0.29)** 0.43 1.40 (0.33) 0.10
12 monthsf 1.32 (0.34)** 0.38 1.30 (0.29)** 0.51 5.52 0.01
Coping, handle responsibility, attention, concentration, work, tolerate stress
Baselined 1.44 (0.41) 1.42 (0.44)
3 monthse 1.31 (0.38)** 0.36 1.48 (0.55) −0.10
12 monthsf 1.36 (0.44)* 0.24 1.31 (0.38)* 0.27 5.80 0.01
Ability to hold, to pick, to write, to drive, to cook, to dress/undress
Baselined 1.37 (0.33) 1.36 (0.33)
3 monthse 1.27 (0.34)** 0.33 1.32 (0.36) 0.08
12 monthsf 1.25 (0.35)* 0.34 1.21 (0.30)** 0.48 3.44 0.04
Ability to stand, to walk flat, to walk stairs, to shop
Baselined 1.55 (0.52) 1.58 (0.50)
3 monthse 1.45 (0.47)** 0.29 1.47 (0.45) 0.19
12 monthsf 1.38 (0.48)** 0.35 1.39 (0.48)** 0.43 1.17 0.31
Ability to lift, to carry, to laundry, to housekeep
Baselined 1.73 (0.51) 1.71 (0.50)
3 monthse 1.53 (0.51)** 0.34 1.58 (0.50)* 0.24
12 monthsf 1.46 (0.47)** 0.50 1.46 (0.42)** 0.63 0.99 0.37
Ability to sit, to be a passenger in car/bus/train
Baselined 1.41 (0.55) 1.42 (0.55)
3 monthse 1.22 (0.41)** 0.39 1.28 (0.47)* 0.21
12 monthsf 1.22 (0.41)** 0.36 1.21.(0.37)** 0.45 1.28 0.28
Ability to communicate verbally, written and by phone, to cooperate, to perceive messengers
Baselined 1.26 (0.35) 1.26 (0.35)
3 monthse 1.24 (0.34) 0.08 1.32 (0.41) −0.12
12 monthsf 1.29 (0.40) −0.06 1.28 (0.37) 0.00 0.76 0.47
Ability to watch TV, listen to radio
Baselined 1.07 (0.19) 1.08 (0.24)
3 monthse 1.06 (0.20) 0.07 1.12 (0.29) −0.12
12 monthsf 1.09 (0.27) −0.18 1.07 (0.24) 0.02 3.77 0.03
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
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effect sizes were similar for the groups, due to improvements in
the BI group from 3 to 12months, leaving the two groups similar.
Changes in Pain
Pain by activity (MI group=6.62 (1.93), BI group=6.26
(2.11)) and back pain (MI group=5.97 (2.28), BI group=
5.69 (2.44)) was the main pain problem in both groups at
baseline. Both groups had reduction in their average pain
levels during the follow-up, but there were no significant dif-
ferences between the groups at 3 or 12 months on pain by
activity or back pain (results not shown).
Use of Health Services by 3 and 12 Months
By 3 and 12 months, the MI group had consulted their GP
significantly less than the MI group (p<0.05): By 3 months
19.4 % in the MI group and 31.8 % in the BI group had
received treatment by their GP during the last 3 months, with
about equal mean number of treatment sessions: MI=3.0 and
BI=2.8. By 12 months, the corresponding numbers were 11.8
and 18.5 %, mean MI=2.5 and BI=2.3 (p<0.05). There were
no significant differences between the groups in consulting
other therapists at 3 or 12 months follow-up.
Changes in Health Complaints/Symptoms, Coping
and Satisfaction with Treatment
By 12months, there were no significant differences between the
groups in self-evaluated changes in complaints (x2 (1, n=171)=
3.4); 85 individuals (96.5%) in theMI group and 86 (98.8%) in
the BI group reported that they still had musculoskeletal com-
plaints. By 12months, theMI group reported significantly better
ability to cope with problems (x2 (1, n=168)=22.5, p<0.001),
Table 3 Effects of
multidisciplinary intervention
(MI) and brief intervention (BI)
on subjective health complaints
(SHC)
MI BI Interaction effectc (time × group)
Mean (SD)a db Mean (SD)a db F value p value
SHC total
Baselined 20.13 (9.38) 18.42 (9.39)
3 monthse 16.12 (8.97)** 0.48 17.34 (10.51)* 0.16
12 monthsf 15.71(10.22)** 0.42 15.25(10.44)** 0.42 2.20 0.11
SHC musculoskeletal complaints
Baselined 10.62 (4.24) 10.07 (4.36)
3 monthse 8.78 (4.37)** 0.47 8.83 (4.62)** 0.30
12 monthsf 8.22 (4.73)** 0.50 7.89 (4.79)** 0.57 1.64 0.20
SHC pseudoneurological symptoms
Baselined 4.96 (3.20) 4.79 (3.59)
3 monthse 3.79 (3.11)** 0.43 4.56 (3.69) 0.11
12 monthsf 3.61 (3.57)** 0.39 3.95 (3.55)** 0.33 1.40 0.25
SHC gastrointestinal symptoms
Baselined 2.67 (2.91) 1.97 (2.53)
3 monthse 2.13 (2.40)* 0.24 2.16 (2.71) 0.02
12 monthsf 2.29 (2.72) 0.15 1.94 (3.27) 0.11 0.29 0.75
SHC allergy symptoms
Baselined 1.13 (1.81) 0.91 (1.43)
3 monthse 0.82 (1.35)* 0.20 0.89 (1.35) −0.03
12 monthsf 0.74 (1.16)* 0.23 0.62 (1.08)* 0.21 2.21 0.11
*p<0.05 and **p<0.01 based on paired samples t test within each group compared with baseline assessment
a Paired t test, comparing baseline and 3 months, and baseline and 12 months. Separate tests for the BI group and
the MI group
b Cohen’s d for paired values. A negative Cohen’s d indicates a worsened score compared to baseline. Small
effect d=0.2, medium effect d=0.5, large effect d=0.8
c A mixed between-within-subjects analyses of variance comparing the effect of the BI and the MI intervention
(Wilks’ lambda),F value and interaction effects. P-values <0.05 indicate significant different time courses for the
two interventions
d Baseline MI: n=139 (98.6 %). BI: n=141(98.6 %)
e 3 months: MI: n=112 (79.4 %). BI: n=95 (66.4 %)
f 12 months: MI: n=85 (60.3 %). BI: n=87 (60.8 %)
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better ability to take care of their own health (x2 (1, n=165)=
17.3, p<0.001) and better physical fitness (x2 (1, n=165)=
15.1, p<0.01) compared to the BI group. The MI group also
reported significantly higher satisfaction with the treat-
ment (x2 (1, n=170)=41.8, p<0.001).
Discussion
Comparing the effects of a multidisciplinary intervention
(MI), including use of the novel Interdisciplinary Structured
Interview with a Visual Educational Tool (ISIVET), with a
brief intervention (BI) on patients sick-listed due to musculo-
skeletal pain, revealed no significant differences between
groups on mental and physical symptoms and functional abil-
ity at 12 months follow-up. However, patients in the MI group
had significantly better effect on anxiety, depression, somati-
zation and functional ability at 3 months follow-up, compared
to the BI group, and at 12 months follow-up, the MI group
reported better ability to cope with their problems, higher abil-
ity to take care of their own health and better physical fitness
in spite of the same level of pain, and they consulted their GP
less than patients in the BI group both at 3 and 12 months.
In Norway, treatment of musculoskeletal pain is primarily
done by the patients’GP. Chronic and more complex cases are
eventually referred to specialist health care [13, 30, 31]. It is
reasonable to assume that our study population consists of
chronic and more complex cases, as they had been sick-
listed for, on average, 147 days and were referred by their
GPs to specialist health care. The GPs had no prior knowledge
that their patients might be enrolled into a clinical study.
Typically, episodes of acute musculoskeletal pain including
LBP recover quickly, but patients who do not recover tend to
have more complex disorders where social factors, work con-
ditions, psychological and somatic factors play together in per-
petuating the condition [5, 32–34]. Clinical psychosocial fac-
tors predict long-term incapacity of musculoskeletal disorders
[35], and multidisciplinary treatments including a psychosocial
approach have been proven effective for complex illnesses [15,
36] and are well accepted in treatment of chronic pain [13, 15,
16]. The MI patients received more extensive, multidisciplin-
ary treatment, compared to the BI patients. This may explain
why theMI was more effective than the BI at 3 months follow-
up, on anxiety, depression, somatization and functional ability.
The baseline mean scores on anxiety and depression were low
for both groups. A tendency to somatization among these pa-
tients where they express stress in somatic symptoms rather
than psychologically might indicate that changes in even low
scores could be of clinical importance.
Improved communication between patient and health profes-
sionals can influence health outcomes and coping in a positive
way [37–39]. ISIVET is constructed to improve communica-
tion, patient involvement, mutual understanding and enhancing
of the therapeutic alliance. Filling in the ISIVET figures with the
therapist may represent a communication where the patient ex-
periences that her/his opinion and experiences are respected and
made relevant, leading to a mutual insight and understanding of
the situation between patient and therapist. In BI, the communi-
cation was a more traditional doctor–patient relationship where
the patient was given information and advices about physical
activity and exercises to improve their muscle pain.
Earlier trials have shown that patients who are engaged in
decision making are more motivated for changes in lifestyle
and their clinical outcomes are better [38, 40]. In shared deci-
sion making (SDM), the patient’s autonomy is strengthened
and the relationship with the therapist and the patient is im-
proved [41]. The application of ISIVET in assessment of
health complaints can facilitate patient empowerment and
SDM. This may lead to improvements of patient satisfaction,
adherence to treatment and better health outcomes [42].
Educational tools can influence the patient’s expectations
and outcomes in a beneficial way compared to traditional
health information [43]. When combining education and
physical exercise, there are some positive long-term effects
for fibromyalgia and musculoskeletal pain [13]. Application
of ISIVETwhere a visualization of the patient’s situation was
established as coloured areas in the ISIVET figures may facil-
itate the patient’s insight and understanding of the complexity
of the situation. This might improve the adherence to the re-
habilitation plan. At 12 months, the MI group reported better
ability to handle health problems and better physical fitness
and they had less use of health care services in spite of fairly
the same levels of pain and health complaints as the BI group.
Limitations and Strengths of the Study
The dropout of treatment was low, but the return of question-
naires at 12 months follow-up (∼60 %, both groups) might
affect the generalizability of the study. However, analyses
showed that non-returners of questionnaires at 12 months
had significantly lower scores onHSCL depression at baseline
compared to returners. Multiple analyses were performed,
possibly increasing the risk of finding low p values by coin-
cidence. The patients in the MI group received more therapist
time, which may have influenced the results. For practical
reasons, there was no blinding of patients or therapists for
the different treatments. The treatment sessions were unfortu-
nately not videotaped, but therapists in the BI group had been
videotaped previously [22]. Manuals were written for both
treatments to ensure equal practice of the methods. The BI
group had fewer and more experienced therapists compared
to the MI group; however, the therapists in the MI group had
regular meetings and supervision. The first author developed
the ISIVET and treated 29 patients. However, the outcomes
were based on the questionnaires that patients filled in at home
before the consultations, not on scores in the ISIVET.
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Conclusions
The results indicate that the new MI may represent an impor-
tant supplement in the multidisciplinary therapeutic work in
patients with chronic musculoskeletal pain and that visualiza-
tion, shared decision and multidisciplinary assessment can
reinforce the effect of treatment. The MI with the ISIVET
should be applied in new studies to see if results could be
reproduced or improved further.
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MANUAL FOR UTFYLLING AV STJERNEDIAGRAM 
 
 
Prinsipp:  Jo høyere score, jo mer positivt og også jo større areal i figuren. 
  1 er laveste score, 10 er høyeste. 
  Du eksemplifiserer hva de ulike nivåene tilsier i praksis. 
Pasienten scorer i forhold til sine egne normer (hva som er godt nok/standard for han/henne) 
 

















fysiske plager som 
setter det meste av 
normal aktivitet til 
side, evt. mest 
sengeliggende, 
dagene domineres av 
disse plagene, ingen 




Har relativt store 
fysiske plager, 
hver dag er 
preget av dette 
og de fleste 
aktiviteter er 
berørt av dette. 
Begrenser mange 
aktiviteter. 
Har moderat uttalt med 
fysiske plager. 
Fungerer greit i forhold 
til mange gjøremål, 
men har også daglig 
visse aktiviteter som 
ikke kan gjennomføres 
el. må ”porsjoneres” ut. 
Fungerer bra i 
forhold til mange 
aktiviteter. Kan ha 
gode dager med 
tilnærmet normal 
funksjon, men 
like vanlig at 
dagene er noe 
preget.  
Ingen fysiske besvær 
utover det som anses 
normalt. Har ingen 
fysiske 
hindringer/begrens-
ninger som er forårsaket 









med angst, indre uro 
eller følelse av 
tristhet, nedstemthet. 










Moderat uttalte plager 
med angst/indre uro 
eller nedstemthet i en 
slik grad at livet ikke 
kjennes så godt som det 
kunne/burde vært 
En viss uro  el. 
bekymring men 
også mange dager 
med fravær av 
slik.  
Helt ordinær følelse av 
indre ro og velvære. 
Ingen nedstemthet eller 
depressive 
tanker/uro/bekymringer 










Dårlig, hver natt er 
preget av søvnløshet 






timer med søvn 
Innsovnings-problemer 
eller problemer med 
mange oppvåkninger 
el. tidlig oppvåkning. 
Redusert søvnkvalitet 





max 1-2 netter per 
uke.  
Sover helt normalt og 
føler seg uthvilt etter 









Føler seg helt tappet 
for krefter og 
overskudd. Store 
problemer med å ta 
initiativ. Passiv. 
Ligger mye.  
Slitenhetsfølelse 
konstant til 
stede. Har sluttet 
med mange 
gjøremål 
Kjenner til daglig på 
manglende overskudd. 
Vegrer seg for 
gjøremål. Må hvile el. 
avstå fra ting daglig 




men dager hvor 
mangel på energi 
dominerer 
Har det nødvendige 



















3-4 ganger ukentlig og 









representerer en stor 
forandring fra slik 
det ellers har vært.  
Helt sporadisk 
sosial deltagelse, 
langt mindre enn 
hva behovet 
tilsier 
Har noe sosial 
deltagelse, men savner 
mer, har klart mindre 
enn behovet egentlig 
tilsier. 
Brukbart men 





Har sosial deltagelse 









75% sykemeldt 50% sykemeldt 25% sykemeldt I full jobb (i sin stilling 















Trives ikke noe 
særlig med 
arbeidsoppgavene 





Synes det er greie 
arbeidsoppgaver. 
Trives godt. 






Helt håpløst (altfor 





med jobb. Føler 





for mye men har 
like mange 
perioder med 
kontroll på sit.  
Godt tilpasset 
arbeidsmengde. 
Føler seg bare av 
og til frustrert 
over 
arbeidsmengde, 
ikke ukentlig.  
 
Perfekt dosering av 
arbeidsmengde, klarer å ta 
unna fortløpende, føler seg 
effektiv og produktiv. 
Tilfredshet 
med grad av 
stress 
Overveldende mye 
stress, hver dag, 
hele tiden. 
Følelse av mangel 
på kontroll hele 
tiden. 
Et stressnivå som 
preger arbeidet på 
et generelt 
grunnlag, stort 
sett daglig og 
kilde til 
frustrasjon mer 














Helt perfekt mengde stress, 
kun positivt det som er. 
God følelse av kontroll. 
Tilfredshet 
med grad av 
utfordringer 
Altfor lite eller mye 
utfordringer. 
Ressursene står 
overhode ikke i 







oppgaver som i 
positiv forstand 





Jevnt over bra 
med utfordringer. 
Langt opp mot 
hva jeg synes er 
tilfredsstillende 
og nødvendig. 
Perfekt samsvar mellom 
utfordringer og ressurser. 
Følelse av ”FLYT”sone. 
Får brukt seg i positiv 
forstand. Opplevelse av 






Avstand og mangel 







en viss belastning 
å forholde seg til 
arbeidsmiljøet. 
Greie relasjoner 






som et ekstra 
pluss ved jobben.  
Svært gode kollegiale 
forhold, støttende og 


















bedring på en 
del områder. 
 
Stort sett fornøyd 
med ledelsen både 
ledelsesfaglig og 
menneskelig 
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